<html xmlns="http://www.w3.org/1999/xhtml"> <head> <style type="text/css">
      	     		 
      	    a                          {background : #ffffff; }
      	    article                    {border-style : dotted; border-width : 2px; }
		 	
		 	div                        {background : #ffffcc;}
		 	div.abstract-title         {font-weight : bold ; font-size : 16pt;}
		 	div.ack                    {border-style : solid ; border-color : red; margin : 2em; }
		 	div.article-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.boxed-text             {margin : 5em; border-style : solid;}
		 	div.contrib-group          {margin : 1em; }
		 	div.fig                    {border-style : solid; border-width : 2px; margin : 2em; }
		 	div.funding                {font-weight : bold ; font-size : 16pt;}
		 	div.given-names            {font-style : italic;}
		 	div.intro                  {border-style : inset; margin : 5px;}
		 	div.introduction           {border-style : inset; margin : 5px;}
		 	div.journal-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.journal-title-group    {background : #ffeeee;}
		 	div.article-title          {font-weight : bold ; font-size : 18pt;}
		 	div.kwd                    {font-style : italic}
		 	div.meta-name              {font-weight : bold ; font-size : 16pt;}
		 	div.name                   {font-weight : bold;}
		 	div.alt-title              {font-style : italic; font-size : 12px;}
		 	
		 	div.sec                    {border : 2px; margin 5px; padding 2px;}
		 	div.title                  {font-family : courier; font-weight : bold;
		 	                            font-size : 16pt; margin : 5px;}
		 	
		 	div.materials_methods      {border-style : double; margin : 5px; }
		 	div.methods                {border-style : double; margin : 5px; }
		 	
		 	div.results                {border-style : solid; margin : 5px;}
		 	div.background             {border-style : dotted; margin : 5px;}
		 	
		 	div.discussion             {border-style : groove; margin : 5px;}
		 	div.conclusion             {border-style : ridge; margin : 5px;}
		 	div.conclusions             {border-style : ridge; margin : 5px;}
		 	div.supplementary-material {border-style : inset; margin : 5px;}
		 	div.abbreviations          {border-style : double; border-color : red; margin : 5px;}
		 	div.competinginterests     {border-style : double; border-color : blue; margin : 5px;}
		 	div.acknowledgements       {border-style : double; border-color : green; margin : 5px;}
		 	div.authors_contributions   {border-style : double; border-color : purple; margin : 5px;}
		 	
		 	div.publisher              {border-style : outset; margin : 5px;}
		 	div.fn-type-conflict       {background : #f88; }
		 	div.fn-type-con            {background : #ddf; }
		 	div.fn-type-other          {background : #ddd; }
		 	
		 	div.unknown                {background : #ffd;
									 	  border-style : solid;
									 	  border-width : 1px;
									 	  padding : 2 px;}
		 	  
      	    table                      {background : #ffffdd;}
		 	tr                         {background : #ddddff; padding : 1px;}
		 	
		 	span                       {background : #ffcccc;}
		 	
		 	span.citation-author       {font-family : helvetica; background : #ffeeee;}
		 	span.collab                {background : #ddffff; }
		 	span.comment               {font-family : courier; font-size : 6px; background : #ffaaff;}
		 	span.contrib               {background : #ffffff;}
		 	span.corresp               {background : #ddffdd; }
		 	span.doi                   {background : #ffffff;}
		 	span.email                 {font-family : courier; }
		 	span.etal                  {font-style : italic;}
		 	span.fpage                 {font-family : courier;}
		 	span.given-names           {background : #ffffff;}
		 	span.iso-abbrev            {background : #ffffff;}
		 	span.issn-epub             {background : #ffffff;}
		 	span.issn-ppub             {background : #ffffff;}
		 	span.journal-title         {background : #ffffff;}
		 	span.lpage                 {font-family : courier;}
		 	span.mixed-article-title   {font-style : italic ;}
		 	span.nlm-ta                {background : #ffffff;}
		 	span.pmc                   {background : #ffffff;}
		 	span.pmcid                 {background : #ffffff;}
		 	span.pmid                  {background : #ffffff;}
		 	span.publisher             {background : #ffffff;}
		 	span.publisher-id          {background : #ffffff;}
		 	span.publisher-name        {background : #ffffff;}
		 	span.source                {background : #ffffff;}
		 	span.subject               {background : #ffffff;}
		 	span.surname               {background : #ffffff;}
		 	span.volume                {font-family : courier; font-weight : bold;}
		 	span.year                  {font-family : courier ; font-style : italic;}
			</style> </head> <body> <div class="front" title="front"> <div class="journal-meta" tagx="journal-meta" title="journal-meta"><span class="nlm-ta" title="nlm-ta">Pharmaceuticals (Basel)</span><span class="iso-abbrev" title="iso-abbrev">Pharmaceuticals (Basel)</span><span class="publisher-id" title="publisher-id">pharmaceuticals</span><div class="journal-title-group" tagx="journal-title-group" title="journal-title-group"><span class="journal-title" tagx="journal-title" title="journal-title">Pharmaceuticals</span></div><span class="issn-epub" tagx="issn" title="issn-epub">1424-8247</span><div class="publisher" tagx="publisher" title="publisher"><span class="publisher-name" tagx="publisher-name" title="publisher-name">MDPI</span></div> </div> <div class="article-meta" tagx="article-meta" title="article-meta"><span class="pmcid" title="pmcid"> pmcid: <a href="http://www.ncbi.nlm.nih.gov/pubmed/7694078">7694078</a></span><span class="pmid" title="pmid"> pmid: <a href="http://www.ncbi.nlm.nih.gov/pubmed/33114724">33114724</a></span><span class="doi" title="doi"> doi: <a href="https://dx.doi.org/10.3390/ph13110343">10.3390/ph13110343</a></span><span class="publisher-id" title="publisher-id">pharmaceuticals-13-00343</span><div class="article-categories" title="article-categories">
: <span class="subject" title="subject">Review</span></div> <div class="title-group" tagx="title-group" title="title-group"> <div class="article-title" title="article-title">
MÄ�nuka Oilâ€"A Review of Antimicrobial and Other Medicinal Properties</div> </div> <div class="contrib-group" title="contrib-group"><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mathew</span><span class="given-names" tagx="given-names" title="given-names">Cynthia</span></span><a href="#af1-pharmaceuticals-13-00343">1</a></span><span class="contrib" title="contrib"><span class="contrib-id" tagx="contrib-id" title="contrib-id">https://orcid.org/0000-0001-7208-2330</span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tesfaye</span><span class="given-names" tagx="given-names" title="given-names">Wubshet</span></span><a href="#af1-pharmaceuticals-13-00343">1</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rasmussen</span><span class="given-names" tagx="given-names" title="given-names">Phil</span></span><a href="#af2-pharmaceuticals-13-00343">2</a></span><span class="contrib" title="contrib"><span class="contrib-id" tagx="contrib-id" title="contrib-id">https://orcid.org/0000-0002-6764-3882</span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Peterson</span><span class="given-names" tagx="given-names" title="given-names">Gregory M</span></span><a href="#af1-pharmaceuticals-13-00343">1</a><a href="#af3-pharmaceuticals-13-00343">3</a></span><span class="contrib" title="contrib"><span class="contrib-id" tagx="contrib-id" title="contrib-id">https://orcid.org/0000-0002-9095-8460</span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bartholomaeus</span><span class="given-names" tagx="given-names" title="given-names">Andrew</span></span><a href="#af1-pharmaceuticals-13-00343">1</a><a href="#af4-pharmaceuticals-13-00343">4</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sharma</span><span class="given-names" tagx="given-names" title="given-names">Manab</span></span><a href="#af1-pharmaceuticals-13-00343">1</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Thomas</span><span class="given-names" tagx="given-names" title="given-names">Jackson</span></span><a href="#af1-pharmaceuticals-13-00343">1</a><a href="#c1-pharmaceuticals-13-00343">*</a></span></div><span class="citation_author_institution" id="af1-pharmaceuticals-13-00343">[1], <span class="email" tagx="email" title="email">Cynthia.Mathew@canberra.edu.au</span><span class="email" tagx="email" title="email">Wubshet.Tesfaye@canberra.edu.au</span><span class="email" tagx="email" title="email">g.peterson@utas.edu.au</span><span class="email" tagx="email" title="email">a.bartholomaeus@uq.edu.au</span><span class="email" tagx="email" title="email">Manab.Sharma@canberra.edu.au</span></span><span class="citation_author_institution" id="af2-pharmaceuticals-13-00343">[2], <span class="email" tagx="email" title="email">hil@phytomed.co.nz</span></span><span class="citation_author_institution" id="af3-pharmaceuticals-13-00343">[3], </span><span class="citation_author_institution" id="af4-pharmaceuticals-13-00343">[4], </span><div class="author-notes" title="author-notes"> <div class="corresp" title="corresp"><span class="label" tagx="label" title="label">*</span>Correspondence: <span class="email" tagx="email" title="email">jackson.thomas@canberra.edu.au</span></div> </div><span class="pub-date-epub" title="pub-date-epub">epub: <span>2020-10-10</span></span><span class="pub-date-collection" title="pub-date-collection">collection: <span>2020-11</span></span><span class="volume" tagx="volume" title="volume">13</span><span class="issue" tagx="issue" title="issue">11</span><span class="elocation-id" tagx="elocation-id" title="elocation-id">343</span><span class="history" title="history"><span class="received" title="received">received: 2020-9-14</span><span class="accepted" title="accepted">accepted: 2020-10-09</span></span><div class="permissions"><span class="copyright" title="copyright">(C) , <span class="copyright-year" tagx="copyright-year" title="copyright-year">2020</span></span><span class="license" title="license"><span class="license-p" title="license-p">Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<a href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</a>).</span></span></div> <div class="abstract" title="abstract"> <div class="abstract-title" title="abstract-title">
Abstract</div> <p>MÄ�nuka oil is an essential oil derived from <i>Leptospermum scoparium</i>, a plant that has been used by the indigenous populations of New Zealand and Australia for centuries. Both the extracted oil and its individual components have been associated with various medicinal properties. Given the rise in resistance to conventional antibiotics, natural products have been targeted for the development of antimicrobials with novel mechanism of action. This review aimed to collate available evidence on the antimicrobial, anti-parasitic and anti-inflammatory activities of mÄ�nuka oil and its components. A comprehensive literature search of was conducted using PubMed and Embase (via Scopus) targeting articles from database inception until June 2020. Chemical structures and IUPAC names were sourced from PubChem. Unpublished information from grey literature databases, Google search, targeted websites and Google Patents were also included. The present review found extensive in vitro data supporting the antimicrobial effects of mÄ�nuka oil warrants further clinical studies to establish its therapeutic potential. Clinical evidence on its efficacy, safety and dosing guidelines are necessary for its implementation for medical purposes. Further work on regulation, standardization and characterization of the medicinal properties of mÄ�nuka oil is required for establishing consistent efficacy of the product.</p> </div> <div class="kwd-group"> <div class="kwd" title="kwd">
mÄ�nuka oil</div> <div class="kwd" title="kwd"><i>Leptospermum scoparium</i></div> <div class="kwd" title="kwd">
antimicrobial</div> <div class="kwd" title="kwd">
antibacterial</div> <div class="kwd" title="kwd">
antiparasitic</div> <div class="kwd" title="kwd">
medicinal</div> <div class="kwd" title="kwd">
therapeutic properties</div> </div> </div> </div> <div class="body" title="body"> <div class="intro" title="intro"> <div class="title" tagx="title" title="title">
1. Introduction</div> <p>MÄ�nuka (<i>Leptospermum scoparium</i>), also known as kahikatoa, red mÄ�nuka and tea tree, belongs to the <i>Myrtaceae</i> plant family and is found throughout New Zealand and Australia [<a href="#B1-pharmaceuticals-13-00343">1</a>]. Commonly grouped under â€˜tea trees,â€™ which also includes <i>Camellia sinensis, Kunzea ericoides</i>, <i>Leptospermum petersonii</i> and <i>Melaleuca alternifolia</i>, these species have been used by the MÄ�ori, the Aboriginals and early European settlers as topical preparations for wounds, cuts, sores and skin diseases and as inhalations for colds and fevers. Interest in the medicinal properties of mÄ�nuka, particularly mÄ�nuka honey, has grown over the last 30 years. There is also a growing interest in the volatile oil due to its potential application as a medicinal agent or cosmetic ingredient [<a href="#B2-pharmaceuticals-13-00343">2</a>,<a href="#B3-pharmaceuticals-13-00343">3</a>]. Currently, there has not been a critical review on the efficacy and potential applications of mÄ�nuka oil while there have been extensive reviews on MÄ�nuka honey and its medical applications. We aim to bridge this gap through this review, providing an up-to-date summary of recent developments in our understanding of the medicinal activities of mÄ�nuka oil as well as its clinical efficacyâ€"and toxicity profile.</p> </div> <div class="2.searchstrategy" title="sec"> <div class="title" tagx="title" title="title">
2. Search Strategy</div> <p>Literature search was conducted using PubMed and Embase (via Scopus) targeting articles from database inception until June 2020. Key terms like â€˜<i>Leptospermum scoparium</i>â€™ and â€˜antimicrobialâ€™ or â€˜antibacterialâ€™ or â€˜anti-inflammatoryâ€™ or â€˜antiviralâ€™ were tailored for individual databases to perform the search (a full search strategy is summarized in <a href="#app1-pharmaceuticals-13-00343">Appendix A</a>). The retrieved articles were filtered manually to exclude duplicates and then screened using titles, abstracts and full-text articles based on our objectives. Also, bibliographies of included studies were reviewed to check for articles missed during the main search. Chemical structures and IUPAC names were obtained from PubChem. Information was also gathered from grey literature databases, Google search, targeted websites and Google Patents.</p> <div class="2.1.chemicalcomposition" title="sec"> <div class="title" tagx="title" title="title">
2.1. Chemical Composition</div> <p>MÄ�nuka oil (CAS 219828- 87-2) is a volatile essential oil derived from the foliage, bark and seeds of <i>Leptospermum scoparium</i> plants of the <i>Myrtaceae</i> family of trees and shrubs [<a href="#B4-pharmaceuticals-13-00343">4</a>]. A clear liquid with an aromatic odor is produced by a steam distillation process from plants harvested mostly in the autumn, summer and spring, with a yield ranging from 0.2â€"1%, depending on seasonal and geographical factors [<a href="#B5-pharmaceuticals-13-00343">5</a>,<a href="#B6-pharmaceuticals-13-00343">6</a>] (also commercial data held by Phytomed Medicinal Herbs Ltd., Auckland, New Zealand). The oil is generally distilled using leaves and young stems, although oil has also been produced from the seeds [<a href="#B5-pharmaceuticals-13-00343">5</a>,<a href="#B7-pharmaceuticals-13-00343">7</a>]. The use of biowaste fertilizer has recently been reported to enhance oil production and content [<a href="#B8-pharmaceuticals-13-00343">8</a>].</p> <p>A large number of studies have examined the constituents of mÄ�nuka oil, which vary depending on the source of the oil [<a href="#B7-pharmaceuticals-13-00343">7</a>,<a href="#B9-pharmaceuticals-13-00343">9</a>,<a href="#B10-pharmaceuticals-13-00343">10</a>] as well as the plant chemotype and season of collection [<a href="#B11-pharmaceuticals-13-00343">11</a>]. Overall, 100 components were identified from 16 commercial samples of mÄ�nuka oil, of which 51 components made up 95% of the content [<a href="#B7-pharmaceuticals-13-00343">7</a>]. The major components of commercially available mÄ�nuka oils are reported to be leptospermone (0.8â€"19.4%), calamenene (2.5â€"18.5%), Î´-cadinene (0.9â€"6.9%), cadina-1,4-diene (0.1â€"5.9%), flavesone (0.7â€"5.8%), cadina-3,5-diene (3.0â€"10.0%), Î±-copaene (4.3â€"6.5%) and Î±-selinene (1.3â€"5.0%) (<a href="#pharmaceuticals-13-00343-t001">Table 1</a>) [<a href="#B7-pharmaceuticals-13-00343">7</a>,<a href="#B9-pharmaceuticals-13-00343">9</a>,<a href="#B11-pharmaceuticals-13-00343">11</a>,<a href="#B12-pharmaceuticals-13-00343">12</a>,<a href="#B13-pharmaceuticals-13-00343">13</a>,<a href="#B14-pharmaceuticals-13-00343">14</a>]. Chemotypes found in the East Coast of the North Island of New Zealand tend to contain higher levels of Î²-triketones than oil sourced from other regions [<a href="#B11-pharmaceuticals-13-00343">11</a>]. The compartmentalization of Î²-triketones and grandiflorone within oil glands inside mÄ�nuka leaves may defend the plants against mÄ�nukaâ€™s herbicidal activity [<a href="#B15-pharmaceuticals-13-00343">15</a>]. There are also some types of <i>L. scoparium</i> that are high in Î±-pinene (21.5%) [<a href="#B11-pharmaceuticals-13-00343">11</a>], though the majority of plants possess lower levels of this monoterpene (0.6â€"11%) [<a href="#B7-pharmaceuticals-13-00343">7</a>,<a href="#B9-pharmaceuticals-13-00343">9</a>,<a href="#B10-pharmaceuticals-13-00343">10</a>,<a href="#B11-pharmaceuticals-13-00343">11</a>].</p> <p>Variation of the components in mÄ�nuka oil was found both between and within natural populations of <i>L. scoparium</i> [<a href="#B7-pharmaceuticals-13-00343">7</a>,<a href="#B11-pharmaceuticals-13-00343">11</a>,<a href="#B16-pharmaceuticals-13-00343">16</a>]. Higher levels of triketones (known to have strong antibacterial properties) were predominant in samples from the East Cape population. Higher levels of the monoterpenes, Î±- and Î²-pinene, were present in the Northland populations [<a href="#B16-pharmaceuticals-13-00343">16</a>]. Samples from <i>L. scoparium</i> grown in Australia had higher monoterpene levels and almost no triketones compared to those from New Zealand [<a href="#B16-pharmaceuticals-13-00343">16</a>]. MÄ�nuka oil from New Zealand was shown to have low concentrations of monoterpenes in comparison to kanuka oil (75% Î±-pinene) and negligible amounts of terpinen-4-ol and 1,8-cineole predominant in Australian tea tree oil [<a href="#B7-pharmaceuticals-13-00343">7</a>]. In general, mÄ�nuka oils from different geographic locations around New Zealand can be simplified into 3 basic chemo-type groups based on the ratio of the monoterpenes:sesquiterpenes:ÃŸ-triketones [<a href="#B29-pharmaceuticals-13-00343">29</a>]. These include triketone-rich in the East Cape (marketed as Manexâ"¢), monoterpene-, linalool- and eudesmol-rch in Nelson (Kaiteriteriâ"¢) and monoterpene- and pinene rich in Canterbury [<a href="#B5-pharmaceuticals-13-00343">5</a>,<a href="#B9-pharmaceuticals-13-00343">9</a>,<a href="#B16-pharmaceuticals-13-00343">16</a>,<a href="#B30-pharmaceuticals-13-00343">30</a>]. A varied chemotype in mÄ�nuka grown in South Africa in comparison to New Zealand-grown was shown by van Vurren [<a href="#B31-pharmaceuticals-13-00343">31</a>]. The age of the plant also plays a role in the nature of the essential oil, with higher sesquiterpene content in young plants and a mixed amount of monoterpenes and sesquiterpenes in mature ones [<a href="#B9-pharmaceuticals-13-00343">9</a>]. </p> <p>The lack of consistency in constituents is a common problem with natural extracts and a source of inconsistency in medicinal properties [<a href="#B32-pharmaceuticals-13-00343">32</a>]. Though mÄ�nuka oil is listed under the New Zealand Inventory of chemicals (CAS 219828- 87-2), ECHA (CAS 223749-44-8) and EINECS (425-630-7), further research into regulation, standardization and characterization of the medicinal properties from varying origins is required.</p> </div> <div class="2.2.medicinalpropertiesofmÄ�nukaoil" title="sec"> <div class="title" tagx="title" title="title">
2.2. Medicinal Properties of MÄ�nuka Oil</div> <p>MÄ�nuka grows abundantly throughout New Zealand and has been a part of traditional Maori medicine for a variety of applications. The bark of the tree has been used for the treatment of skin diseases, as a sedative and as a mouthwash. The leaves are boiled in water for treating colds or crushed and applied to ease itching and scabs, while the leaves have been used as tea, as a febrifuge and for pain relief. The seeds were used for treating dysentery and diarrhea [<a href="#B33-pharmaceuticals-13-00343">33</a>,<a href="#B34-pharmaceuticals-13-00343">34</a>]. Contemporary data, prominently from in vitro studies, clearly demonstrates a broad spectrum of antibacterial, antifungal, anti-parasitic/insecticidal, anti-inflammatory, antiviral and spasmolytic activity.</p> </div> <div class="2.3.antibacterialactivity" title="sec"> <div class="title" tagx="title" title="title">
2.3. Antibacterial Activity</div> <p>The antibacterial activity of mÄ�nuka oil is the most characterized, being effective against both Gram-positive and Gram-negative bacteria (<a href="#pharmaceuticals-13-00343-t002">Table 2</a>). These effects are variable depending on the type and source of the oil, with fractions containing triketone constituents seeming particularly active [<a href="#B10-pharmaceuticals-13-00343">10</a>].</p> </div> <div class="2.4.mechanismofaction" title="sec"> <div class="title" tagx="title" title="title">
2.4. Mechanism of Action</div> <p>The antibacterial activity of mÄ�nuka oil is relatively more pronounced against Gram positive bacteria than Gram negative bacteria (<a href="#pharmaceuticals-13-00343-t002">Table 2</a>). The exact mechanism of the antibacterial effects in Gram positive bacteria are unknown but cell lysis of Gram-positive cells suggests disruption of the bacterial cell membrane is an important component of the mechanism. Treatment with 1.5% (<i>v/v</i>) of mÄ�nuka oil for 4 h induced morphological changes and cell lysis in methicillin-resistant <i>Staphylococcus aureus</i> (MRSA), while treatment with a high dose (3% <i>v/v</i>) completely disrupted the cells [<a href="#B35-pharmaceuticals-13-00343">35</a>]. The Î²-triketone content are suggested to be responsible for this activity [<a href="#B30-pharmaceuticals-13-00343">30</a>]. In contrast treatment with mÄ�nuka oil against Gram negative bacteria, such as <i>E. coli</i>, caused mild alterations in morphology at low doses and higher concentrations (6% <i>v/v</i>) were required for antibacterial effects [<a href="#B12-pharmaceuticals-13-00343">12</a>,<a href="#B35-pharmaceuticals-13-00343">35</a>]. The basis of the difference is unknown but this may be due to limited diffusion across the lipopolysaccharide-based capsule covering the outer membrane of Gram negative bacteria [<a href="#B35-pharmaceuticals-13-00343">35</a>]. </p> </div> <div class="2.5.grampositivebacteria" title="sec"> <div class="title" tagx="title" title="title">
2.5. Gram Positive Bacteria</div> <p>The efficacy of mÄ�nuka oil is both dose- and time-dependent. Treatment with a 10% solution of mÄ�nuka oil in DMSO was equally effective as the same concentration of kanuka oil against <i>Staphylococcus aureus, Staphylococcus sobrinus and Staphylococcus mutans</i> (Minimum Inhibitory Concentration (MIC) = 0.048% (480 Âµg/mL); the highest dilution at which no growth was observed) [<a href="#B36-pharmaceuticals-13-00343">36</a>] (<a href="#pharmaceuticals-13-00343-t002">Table 2</a>). A time to kill assay against the same strains showed 100% inhibition on treatment with either 10% mÄ�nuka oil or kanuka oil required as low as 5 s and as high as 900 s [<a href="#B37-pharmaceuticals-13-00343">37</a>]. Another study determined the MIC value ranging between 0.13â€"0.25% against <i>S. sobrinus</i> strains and 0.25% against <i>S. mutans</i> [<a href="#B38-pharmaceuticals-13-00343">38</a>]. Higher concentrations of essential oils are reported in the case of other antibacterial medicinal products against the same oral pathogensâ€"tea tree (1%), eucalyptus (1%), lavender (&amp;gt;1%) and rosemary (&amp;gt;1%) [<a href="#B38-pharmaceuticals-13-00343">38</a>] (<a href="#pharmaceuticals-13-00343-t002">Table 2</a>). </p> <p>MÄ�nuka oil exhibits strong bacteriostatic effects against different strains of <i>Staphylococcus</i>, including antibiotic-resistant strains (<a href="#pharmaceuticals-13-00343-t002">Table 2</a>). Treatment with 2% (<i>v/v</i>) mÄ�nuka oil, kanuka oil or triketones in Tween 80 had limited bactericidal effects at 240 min post-treatment (using death a kinetics assay) [<a href="#B30-pharmaceuticals-13-00343">30</a>]. MÄ�nuka oil has also exhibited strong activity against different strains of <i>Staphylococcus pseudintermedius,</i> often contributory to skin and ear infections in dogs [<a href="#B39-pharmaceuticals-13-00343">39</a>]. These included methicillin-resistant strains, with MICs being around 2% (<i>v/v</i>) for both resistant- and antibiotic-sensitive isolates [<a href="#B39-pharmaceuticals-13-00343">39</a>]. Inhibition of <i>S. pseudintermedius</i> biofilm formation was also reported in the same study [<a href="#B39-pharmaceuticals-13-00343">39</a>]. Exposure of various strains of <i>S. aureus</i> to subinhibitory concentrations of mÄ�nuka oil has also been found to significantly inhibit their ability to produce enterotoxins, an effect not observed after treatment with oregano and marjoram essential oils [<a href="#B36-pharmaceuticals-13-00343">36</a>,<a href="#B40-pharmaceuticals-13-00343">40</a>]. </p> <p>Activity against <i>Staphylococcus epidermidis</i> and <i>Propionibacterium acnes</i>, pathogenic bacteria responsible for acne in humans, has also been reported [<a href="#B41-pharmaceuticals-13-00343">41</a>,<a href="#B42-pharmaceuticals-13-00343">42</a>]. Interestingly, this study also found mÄ�nuka oil to show the highest likelihood amongst a range of different essential oil combinations, of being involved in synergist interactions against <i>S. epidermidis</i> [<a href="#B41-pharmaceuticals-13-00343">41</a>]. Kim et al. and Wu (2011) have shown reduction in acne and bactericidal effects (MIC = 0.211% <i>w/v</i> or 2.11 mg/mL; MBC = 0.25% <i>w/v</i> or 2.5 mg/mL) of mÄ�nuka oil against <i>P. acnes</i> respectively [<a href="#B42-pharmaceuticals-13-00343">42</a>,<a href="#B43-pharmaceuticals-13-00343">43</a>].</p> <p>Impressive effects of mÄ�nuka oil have been found against pathogenic bacteria associated with biosolid soil contamination, with significant growth inhibition of <i>C. perfringens</i> and <i>L. monocytogenes</i> [<a href="#B44-pharmaceuticals-13-00343">44</a>]. The EC<sub>50</sub> = 0.07% and 23.3% (environmental effect concentration is the dose required to reduce pathogen growth by 50%) for <i>C. perfringens</i> and <i>L. monocytogenes,</i> respectively, on treatment with concentrated mÄ�nuka leaf extract for 24 h [<a href="#B44-pharmaceuticals-13-00343">44</a>].</p> <p>Specific components or fractions of mÄ�nuka oil, such as leptospermone (and its derivatives, grandiflorone and myrigalone A), have also been identified to possess antibacterial activity [<a href="#B19-pharmaceuticals-13-00343">19</a>,<a href="#B45-pharmaceuticals-13-00343">45</a>]. Leptospermone had the strongest inhibitory effect against foodborne Gram positive bacteria, such as <i>Listeria monocytogenes, S. aureus and S. intermedius</i> (<a href="#pharmaceuticals-13-00343-t002">Table 2</a>), using both dilution assay and agar diffusion assay (â‰¥30 mm inhibition zone on treatment with 1 and 2 mg/disc) [<a href="#B19-pharmaceuticals-13-00343">19</a>]. Leptospermone and its derivative 1,2,3-cyclohexanetrione-1,3-dioxime had strong inhibitory effects against intestinal bacteria, <i>Clostridium difficle</i> and <i>C. perfringens</i> (inhibitory zone ranged between 20 and &amp;gt;30 mm on treatment with 2 or 5 mg/disc) [<a href="#B19-pharmaceuticals-13-00343">19</a>]. The derivative 1,2,3-cyclohexanetrione-1,3-dioxime had a strong inhibitory effect against <i>Bifidobacterium breve</i> and <i>B. longum</i> (â‰¥30 mm inhibition zone on treatment with 5 mg/disc) but leptospermum had no effect on these strains. Neither fractions were effective against <i>Lactobacillus casei</i>, a non-pathogenic probiotic [<a href="#B19-pharmaceuticals-13-00343">19</a>]. </p> <p>Two other components of typical mÄ�nuka oil, grandiflorone (MIC = up to 0.0032% or 32 Î¼g/mL) and myrigalone A (MIC = 0.0064% or 64 Î¼g/mL), have also been identified as active against vancomycin-resistant <i>Enterococcus faecalis</i> (VRE) and methicillin-resistant <i>S. aureus</i> (MRSA) and may therefore provide potential treatments for infection with these bacterial species [<a href="#B45-pharmaceuticals-13-00343">45</a>]. </p> </div> <div class="2.6.gramnegativebacteria" title="sec"> <div class="title" tagx="title" title="title">
2.6. Gram Negative Bacteria</div> <p>A comprehensive study of the effects of 60 different essential oils on the growth of <i>Helicobacter pylori</i> (<i>H. pylori</i>) found mÄ�nuka oil to be the seventh most effective antibacterial when diluted in propylene glycol (500 Âµg/mL after 1 h and 40 Âµg/mL after 24 h) [<a href="#B46-pharmaceuticals-13-00343">46</a>]. MÄ�nuka oil derived from the North Island of New Zealand displayed significant antibacterial activity against 20/20 <i>Listeria monocytogenes</i> strains, whereas more so than that of mÄ�nuka oil from the South Island was effective against (0/20 <i>Listeria monocytogenes</i> strains) [<a href="#B28-pharmaceuticals-13-00343">28</a>]. Higher levels of Î²-triketones found in chemotypes growing in the North Island of New Zealand, are likely to be contributory to these differences [<a href="#B11-pharmaceuticals-13-00343">11</a>]. </p> <p>Investigation of the growth inhibitory effect of an oil from mÄ�nuka seeds against <i>Escherichia coli</i> showed it to be ineffective according to Jeong et al. (2009) while it was effective for Prosser et al. (2014). Based on calorimetric growth experiments using <i>E. coli</i> K12 C600, Jeong et al. (2009) showed that treatment with different doses of mÄ�nuka oil dissolved in Tween 80 (up to 4% <i>v/v</i>) had a dose-dependent effect in reducing bacterial growth but was not as effective as treatment with <i>Melaleuca alternifolia</i> oil [<a href="#B47-pharmaceuticals-13-00343">47</a>]. On the other hand, Prosser et al. (2014) showed treatment with a very high dose of concentrated mÄ�nuka oil inhibited the growth of <i>E. coli</i> 0157 (EC<sub>50</sub> = 27.8%). Similar doses were required to inhibit the growth of <i>Salmonella typhimurium</i>. In comparison, treatment with 0.597% of concentrated mÄ�nuka oil was sufficient to retard the growth of <i>C. jejuni</i> [<a href="#B44-pharmaceuticals-13-00343">44</a>]. This study proposed the potential applications to improve polluted soils and adjacent waterways, through planting mÄ�nuka or including mÄ�nuka oil when biosolids are applied to the soil to help prevent bacterial contamination [<a href="#B44-pharmaceuticals-13-00343">44</a>,<a href="#B48-pharmaceuticals-13-00343">48</a>].</p> <p>MÄ�nuka-derived leptospermone has strong antibacterial activity against Gram negative foodborne bacterial pathogens, <i>Salmonella typhimurium</i>, <i>Shigella flexneri</i> and <i>Shigella sonnei</i>, with MICs ranging from 23.6 to 69.7 Î¼g/mL [<a href="#B49-pharmaceuticals-13-00343">49</a>]. These data suggest that leptospermone may be useful clinically or as a natural food preservative, as it is able to inhibit the growth of harmful gut and foodborne bacteria while displaying no significant effect on beneficial bacterial species [<a href="#B49-pharmaceuticals-13-00343">49</a>]. </p> <p>Activity against various Gram negative, antibiotic-resistant bacterial isolates from dogs with otitis externa, has also been reported recently for mÄ�nuka. These included both antibiotic-sensitive and multidrug-resistant clinical isolates of <i>Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae spp. pneumoniae</i> and <i>Proteus mirabilis</i> [<a href="#B50-pharmaceuticals-13-00343">50</a>]. MIC and MBC values (minimum bactericidal concentrations) of mÄ�nuka oil alone were â‰¥1% <i>v/v</i> and â‰¥2%, respectively [<a href="#B50-pharmaceuticals-13-00343">50</a>].</p> <p>MÄ�nuka oil was the most effective against periodontopathic bacteria in comparison to tea tree oil, eucalyptus oil, lavandula oil and romarinus oil. MÄ�nuka oil was effective at very low concentration (MIC = 0.03%) against the oral pathogens <i>A. actinomycetemcomitans</i> (MBC = 0.13%)<i>, P. gingivalis</i> (MBC = 0.06; 0.03 for ATCC 53977) and <i>F. nucleatum</i> (MBC = 0.03%). By comparison, higher MIC values very observed for other antibacterial essential oils such as tea tree (0.06â€"0.5%), eucalyptus (0.13â€"0.5%), lavender (0.25â€"1.0%) and rosemary (0.5â€"1.0%) against the same oral pathogens [<a href="#B38-pharmaceuticals-13-00343">38</a>]. </p> </div> <div class="2.7.synergisticeffects" title="sec"> <div class="title" tagx="title" title="title">
2.7. Synergistic Effects</div> <p>Combining mÄ�nuka oil with Tris-EDTA enhanced the antibacterial effects against drug-resistant isolates from dogs with otitis externa, with MIC value ranging from 0.06% to 0.5% and MBC value ranging from 0.06 to 1% [<a href="#B50-pharmaceuticals-13-00343">50</a>]. A placebo-controlled study of bacterial pyoderma in dogs examined the effects of combining systemic antibiotics with a topical spray composed of essential oils, including mÄ�nuka oil [<a href="#B51-pharmaceuticals-13-00343">51</a>]. The results showed a significant improvement in skin healing with the combination of oral antibiotics and essential oil spray, compared to oral antibiotics alone [<a href="#B51-pharmaceuticals-13-00343">51</a>]. </p> <p>Similar results highlighting the synergistic effects of mÄ�nuka oil were shown by Filoche (2005). The combined effect of chlorhexidine digluconate and a series of essential oils, including mÄ�nuka oil, found that mÄ�nuka oil inhibited the growth of two cariogenic bacteria, <i>S. mutans</i> and <i>Lactobacillus plantarum,</i> either as liquid cultures or as biofilms [<a href="#B52-pharmaceuticals-13-00343">52</a>]. When mÄ�nuka oil and chlorhexidine were combined, the authors found an eight-fold reduction in the concentration of chlorhexidine required to achieve the same level of growth inhibition, suggesting the potential for novel anti-caries treatments [<a href="#B52-pharmaceuticals-13-00343">52</a>]. </p> <p>Combined treatment with <i>Cananga odorata</i> and mÄ�nuka oil had MIC = 0.094% (0.94 mg/mL) and 0.060% (0.60 mg/mL) against acne-causing <i>Propionibacterium acnes</i> (ATCC 11827) and <i>Staphylococcus epidermidis</i> (ATCC 2223), respectively. In comparison, treatment with each oil individually required higher doses (<a href="#pharmaceuticals-13-00343-t002">Table 2</a>) (Orchard, 2018). Combined treatment with mÄ�nuka oil and <i>Achillea millefolium</i> or <i>Citrus aurantium</i> var. <i>amara</i> flower (neroli) had MIC = 1.0 mg/mL and 2.0 mg/mL against <i>P. acnes</i> and <i>S. epidermidis,</i> respectively, in the same study [<a href="#B41-pharmaceuticals-13-00343">41</a>].</p> </div> <div class="2.8.antifungalactivity" title="sec"> <div class="title" tagx="title" title="title">
2.8. Antifungal Activity</div> <p>A summary of the antifungal effects of mÄ�nuka oil is given in <a href="#pharmaceuticals-13-00343-t003">Table 3</a>. Although the exact mechanism of action is unknown, the essential oil from Melaleuca alternifolia (tea tree) has been shown to cause damage to the fungal cell wall and cytoplasmic membrane thereby altering the membranes properties and disrupting their functions. Melaleuca oil also causes thinning and distortion of the hyphal wall, causing cell wall disruption and formation of empty hyphal tips that create bud-like structures [<a href="#B54-pharmaceuticals-13-00343">54</a>].</p> <p>Moderate rate of inhibition of phytopathogenic fungi Phytophthora cactorum (28 Ã— 103 mg/mL air), Cryphonectria parasitica (14 Ã— 103 mg/mL air) and Fusarium circinatum (7 Ã— 103 mg/mL air) was revealed fumigant assay [<a href="#B55-pharmaceuticals-13-00343">55</a>]. When the fungi were exposed to mÄ�nuka oil as a fumigant, the inhibition rate was 50% against <i>P. cactorum</i> and 62% against F. circinatum; however, no inhibition was observed against C. parasitica [<a href="#B55-pharmaceuticals-13-00343">55</a>]. </p> <p>The effect of mÄ�nuka oil on Aspergillus niger, A. ochraceous and F. culmorum was assessed in another study, which found wide variation in the antifungal activity depending on the source of mÄ�nuka oil; the mÄ�nuka oil sample from the South Island of New Zealand had greater antifungal activity against A. ochraceus and F. culmorum than mÄ�nuka oil from the North Island [<a href="#B28-pharmaceuticals-13-00343">28</a>]. The fungicidal activity of mÄ�nuka oil was assessed for a series of human fungal species, Malassezia furfur, Trichosporon mucoides, Candida albicans and C. tropicalis, with a MIC of 1.56% for M. furfur and T. mucoides and 3.13% for both Candida species [<a href="#B37-pharmaceuticals-13-00343">37</a>]. Good activity against Candida species was also reported in a subsequent study [<a href="#B56-pharmaceuticals-13-00343">56</a>].</p> </div> <div class="2.9.antiparasitic/insecticidalactivity" title="sec"> <div class="title" tagx="title" title="title">
2.9. Antiparasitic/Insecticidal Activity</div> <p>Several studies have examined the antiparasitic activity of mÄ�nuka oil, for parasites with significant impact on plants, humans and animals (<a href="#pharmaceuticals-13-00343-t004">Table 4</a>). The primary animal parasites under investigation have been poultry red mites (<i>Dermanyssus gallinae</i>), while the primary human parasites investigated have been scabies (<i>Sarcoptes scabei</i>), house dust mites (<i>Dermatophagoides farina</i> and <i>D. pteronyssinus</i>), stored product mites (<i>Tyrophagus putrescentiae</i>) and mosquitos (<i>Aedes aegypti</i>). The adsorption of the active ingredients in the oil are suggested to cause fumigant and/or contact toxicity in the parasites. Contact and fumigation assays are generally used to determine the antiparasitic efficacy of essential oils. The compound efficacy would therefore depend on their lipophilic nature, viscosity and vapor pressure. In contact bioassays, lipophilic and viscous compounds are commonly more effective as they penetrate the cuticle layer of the arthropod. In fumigation bioassays, the toxic compounds are inhaled via the respiratory system and are dependent on the vapor pressure exerted by the compound [<a href="#B57-pharmaceuticals-13-00343">57</a>].</p> <p>A study of the effect of mÄ�nuka oil on different life stages of <i>D. gallinae</i> suggests it is effective against both adult and juvenile mites but that it is not ovicidal for this parasite [<a href="#B58-pharmaceuticals-13-00343">58</a>]. A study of the effect of mÄ�nuka oil on <i>D. gallinae</i> found the lethal concentration required to kill 50% of the parasites (LC<sub>50</sub>) during a 24-h period in a contact bioassay was ~0.05 mg/cm<sup>3</sup> and 0.03 mg/cm<sup>3</sup> [<a href="#B58-pharmaceuticals-13-00343">58</a>]. MÄ�nuka oil displayed a repelling effect on &amp;gt;75% of <i>D. gallinae</i> mites for up to 4 days after treatment of the mites contained in the Y-tube of an olfactometer and exposed to either fresh air in one arm of the Y-tube or air containing the volatile components of each essential oil in the other arm [<a href="#B59-pharmaceuticals-13-00343">59</a>,<a href="#B62-pharmaceuticals-13-00343">62</a>]. </p> <p>The effect of mÄ�nuka oil on a poultry beetle (<i>Tenebrio molitor),</i> a beneficial insect in a poultry system, was assessed along with a non-target organism. In this case, the mÄ�nuka oil had no significant effect on beetle mortality compared to the control (~15% vs. ~5%, respectively) [<a href="#B62-pharmaceuticals-13-00343">62</a>]. Similar results for <i>T. molitor</i> exposure to mÄ�nuka oil were observed in another study [<a href="#B59-pharmaceuticals-13-00343">59</a>]. In contrast, exposure of brine shrimp (<i>Artemia salina</i>, an organism commonly used in toxicity testing) to mÄ�nuka oil revealed a 90% mortality rate after exposure to ~0.05 mg/cm<sup>3</sup>, the same concentration as the LC<sub>50</sub> for <i>D. gallinae</i> [<a href="#B59-pharmaceuticals-13-00343">59</a>], indicating potential use of mÄ�nuka oil as a general acaricide may need careful consideration regarding the effect on non-target organisms. </p> <p>MÄ�nuka seed oil appears to be effective against house dust (<i>D. farina</i> and <i>D. pteronyssinus</i>) and stored product mites (<i>Tyrophagus putrescentiae</i>), with a LD<sub>50</sub> (dose required to kill half the members of a tested population after a specified test duration) values of 0.54, 0.67 and 1.21 Âµg/cm<sup>2</sup>, respectively, against the stated parasites; these values are 11.5â€"68.7 times more effective than DEET (<i>N,N</i>-diethyl-3-methylbenzamide), a common chemical treatment to control these mites [<a href="#B20-pharmaceuticals-13-00343">20</a>]. Further analysis of the major components of mÄ�nuka seed oil indicated the main triketone, leptospermone, to be the most active component of mÄ�nuka oil in this study, with LD<sub>50</sub> values of 0.07â€"0.15 ug/cm<sup>2</sup> against <i>D. farina, D. pteronyssinus</i> and <i>T. putrescentiae</i>; these values represent 92.6â€"530.3 times the toxicity of DEET against the same organisms [<a href="#B20-pharmaceuticals-13-00343">20</a>]. </p> <p>A study of the effects of essential oils on human scabies mites (<i>Sarcoptes scabei</i>) found mÄ�nuka oil to be moderately effective against the mites, with median lethal times of 30 min (Â± 7.5 min) after direct contact with a 10% manuka oil solution in paraffin oil. Vapor phase toxicity of mÄ�nuka oil was determined via fumigation assay, where mites were exposed to a filter paper treated with mÄ�nuka oil and mortality was checked every 5 min. Median lethal time for undiluted mÄ�nuka oil was 23 min (Â± 8.7 min) [<a href="#B14-pharmaceuticals-13-00343">14</a>]. </p> <p>Insecticidal activity for mÄ�nuka oil has also been reported against <i>Drosophila suzukii</i>, a fruit fly pest which is a serious economic threat to soft summer fruit. MÄ�nuka oilâ€™s LD<sub>50</sub> for contact toxicity was 0.60 Î¼g/mL for males and 1.10 for females. Triketone components were shown to be contributory to these insecticidal effects [<a href="#B60-pharmaceuticals-13-00343">60</a>]. </p> <p>MÄ�nuka oil has also been used as a lure to attract <i>Xyleborus glabratus</i> (Redbay ambrosia beetle), an exotic wood-borer that transmits the fungal agent (<i>Raffaelea lauricola</i>) responsible for laurel wilt, which has had a severe impact on forest ecosystems in South-East United States [<a href="#B63-pharmaceuticals-13-00343">63</a>,<a href="#B64-pharmaceuticals-13-00343">64</a>].</p> <p>Screening of essential oils for their toxicity against <i>Aedes aegypti</i> (L.) larvae found that mÄ�nuka oil containing calamenene and leptospermone as dominant constituents, exhibited strong larvicidal effects. This suggests potential applications for mÄ�nuka oil in mosquito vector control. These effects were enhanced when mÄ�nuka oil was combined with carvacrol or oregano oil [<a href="#B61-pharmaceuticals-13-00343">61</a>] and with an emulsion made using amylose-N-1-hexadecylammonium chloride [<a href="#B21-pharmaceuticals-13-00343">21</a>]. </p> </div> <div class="2.10.anti-inflammatoryeffects" title="sec"> <div class="title" tagx="title" title="title">
2.10. Anti-Inflammatory Effects</div> <p>Experiments to assess the anti-inflammatory potential of mÄ�nuka oil found that THP-1 cells stimulated with lipopolysaccharide (LPS) and co-treated with 0.1â€"10% mÄ�nuka oil had significantly reduced release of TNF-Î± but there was no significant effect on the release of IL-4 [<a href="#B37-pharmaceuticals-13-00343">37</a>]. This study found no cellular toxicity at an oil concentration of 10%, which contrasts with the results discussed in the toxicity section earlier. The diluent used in the study by Chen et al. was not specified and this discrepancy could be a result of diluting the lipophilic mÄ�nuka oil in aqueous cell culture media. Lis-Balchin et al. (2000) also showed the antioxidant effects of mÄ�nuka oil from the North- and South-islands of New Zealand were more consistent in comparison to kanuka oil [<a href="#B28-pharmaceuticals-13-00343">28</a>]. </p> </div> <div class="2.11.photo-protectiveeffects" title="sec"> <div class="title" tagx="title" title="title">
2.11. Photo-Protective Effects</div> <p>Solar ultraviolet (UV) radiation is the primary environmental factor causing skin damage and consequently premature aging. Kwon et al. (2013) evaluated mÄ�nuka oil (from Coast Biologicals Ltd., Auckland, New Zealand) for its effects against photoaging in UV-B-irradiated hairless mice. After 8 weeks of exposure to UVB radiation, mice that were treated topically with 10% mÄ�nuka oil experienced a reduction in typical UVB-related skin changes, such as skin thickening, appearance of wrinkles and loss of skin collagen [<a href="#B65-pharmaceuticals-13-00343">65</a>]. These effects were associated with inhibition of loss of collagen fibers, reduction of epidermal hyperplasia, suppressed production of proinflammatory cytokines (IL-1Î² and TNF-Î±) and reduced macrophage infiltration, suggesting mÄ�nuka oil can inhibit UVB-associated inflammation in skin [<a href="#B65-pharmaceuticals-13-00343">65</a>]. </p> <p>A nanoemulsion (particle size of 11.93 Âµm) containing mÄ�nuka oil (10% by weight) as the main component along with a Vitamin C derivative (ascorbyl tetraisopalmitate; 2% to 10% by weight) has been used in cosmetic formulations, including skin creams, lotions, essences and cosmetic powders [<a href="#B66-pharmaceuticals-13-00343">66</a>]. The versatile formulation is effective as a whitening, anti-inflammatory agent and for wrinkle improvement [<a href="#B66-pharmaceuticals-13-00343">66</a>]. Treatment for 9 weeks with the mÄ�nuka oil-Vitamin C derivative nanoemulsion in SKH-1 Hairless Mice exposed to artificial photoaging using UV-B irradiation showed increased thickness of the skin within 6 to 8 weeks post-treatment while the control showed no change.</p> </div> <div class="2.12.antiviralactivity" title="sec"> <div class="title" tagx="title" title="title">
2.12. Antiviral Activity</div> <p>Herpes simplex viruses can cause cold sores (usually Herpes simplex virus type 1, HSV-1) or genital herpes (usually Herpes simplex virus type 2, HSV-2) and both can become chronic and recurrent infections sometimes resistant to antiviral drugs [<a href="#B67-pharmaceuticals-13-00343">67</a>]. Pre-treatment with a Î²-triketone-rich mÄ�nuka oil has been reported to exhibit inhibitory effects on HSV-1 and HSV-2 [<a href="#B23-pharmaceuticals-13-00343">23</a>,<a href="#B68-pharmaceuticals-13-00343">68</a>,<a href="#B69-pharmaceuticals-13-00343">69</a>]. RC-37 cells (monkey kidney cells) or the viruses were pre-treated with mÄ�nuka oil for one hour followed by inoculation. Pre-treatment of the virus with the oil significantly inhibited plaque formation in comparison to pre-treatment of the cells alone [<a href="#B23-pharmaceuticals-13-00343">23</a>]. The IC<sub>50</sub> against HSV-1 was 0.96 Âµg/mL (0.0001% <i>v/v</i>) and that for HSV-2 was 0.587 Î¼g/mL (0.00006% <i>v/v</i>) [<a href="#B23-pharmaceuticals-13-00343">23</a>]. Pre-treatment of host cells before viral infection reduced replication of HSV-1 by 41%. Treatment with flavesone and leptospermone alone, two characteristic triketone constituents of mÄ�nuka oil, had similar effects [<a href="#B23-pharmaceuticals-13-00343">23</a>]. Another study reported pre-treatment of acyclovir-resistant isolates of HSV-1 and HSV-2 with 0.001% mÄ�nuka oil reduced the infectivity of the viruses by &amp;gt;99% [<a href="#B69-pharmaceuticals-13-00343">69</a>,<a href="#B70-pharmaceuticals-13-00343">70</a>]. The absence of viral inhibition in pre-treated cells suggests that the oil is likely to exert a direct antiviral effect on HSV before or during adsorption onto the host cells [<a href="#B23-pharmaceuticals-13-00343">23</a>,<a href="#B69-pharmaceuticals-13-00343">69</a>,<a href="#B70-pharmaceuticals-13-00343">70</a>].</p> </div> <div class="2.13.spasmolyticactivity" title="sec"> <div class="title" tagx="title" title="title">
2.13. Spasmolytic Activity</div> <p>Smooth muscle spasmolytic activity has been reported for mÄ�nuka oil in experiments on guinea pig ileum showing a dose-dependent inhibitory effect of mÄ�nuka oil on smooth muscle contractions [<a href="#B71-pharmaceuticals-13-00343">71</a>]. A subsequent study of the components of mÄ�nuka oil showed Î±-terpineol and terpinene-4-ol both produce strong spasmolytic activity in guinea pig ileum, while in contrast, Î±- and Î³-terpinenes displayed spasmolytic activity after an initial spasmogenic action [<a href="#B28-pharmaceuticals-13-00343">28</a>]. A post-synaptic mechanism affecting cAMP to alter potassium channels in the muscle was suggested by the authors as the possible mode of action [<a href="#B28-pharmaceuticals-13-00343">28</a>]. This activity was absent in kanuka oil and neither mÄ�nuka or kanuka oil used cGMP nor behave like potassium channel openers (seen in <i>Melaleuca</i> (tea tree) oil). </p> <p>MÄ�nuka oil and its components were also reported to increase muscle tone in skeletal muscle, evaluating its absorption in chick biventer muscle and rat phrenic nerve diaphragm preparations [<a href="#B28-pharmaceuticals-13-00343">28</a>]. In contrast, both mÄ�nuka oil and <i>Melaleuca</i> oil decreased uterine muscle contractions. Application of either oils showed a decrease in tension (via inhibition of twitch response on stimulating the skeletal muscle nerve) and a weighty increase in resting tone (indicating contracture) when the muscle was stimulated either directly or via the phrenic nerve. the components Î±-terpineol, Î±-terpinene and terpinene-4-ol showing a similar, significant decrease in the force of contractions [<a href="#B28-pharmaceuticals-13-00343">28</a>]. The study suggests the use of these oils for aromatherapy, where they would aid as relaxants for those suffering from stress and anxiety. While these studies involved relatively high doses of a limited number of mÄ�nuka oil samples, whose origins and chemotypes were not well characterized, to isolated tissues in vitro [<a href="#B28-pharmaceuticals-13-00343">28</a>]. The researchers highlighted caution against the use of mÄ�nuka oil as a relaxant during childbirth may be detrimental to the birthing process and should therefore be avoided in this situation [<a href="#B28-pharmaceuticals-13-00343">28</a>]. This suggestion was based on similar properties exhibited by tea tree oil and other essential oils [<a href="#B28-pharmaceuticals-13-00343">28</a>,<a href="#B72-pharmaceuticals-13-00343">72</a>].</p> </div> <div class="2.14.safetyandtolerance" title="sec"> <div class="title" tagx="title" title="title">
2.14. Safety and Tolerance</div> <p>MÄ�nuka oil, like other essential oils, has been classified as safe and tolerable for human use (CAS (US and EU) 223749-44-8; CTFA monograph ID 10572 and EINECS 425-630-7). However, the lack of clinical trials means there is limited data to inform dosing practices and toxicology profiles. The in vitro toxicity of mÄ�nuka oil and its main constituent, leptospermone, tended to vary with cell lines, concentrations tested and method of analysis (<a href="#pharmaceuticals-13-00343-t005">Table 5</a>). Higher cytotoxicity was observed on treatment with mÄ�nuka oil in comparison to leptospermone alone. This suggests additional components of mÄ�nuka oil that makes it more toxic to cell lines. A study of mÄ�nuka oil in human umbilical vein endothelial cells (HUVEC) found treatment with a concentration of 0.2% of mÄ�nuka oil reduced cell viability by ~30% [<a href="#B38-pharmaceuticals-13-00343">38</a>]. Given mÄ�nuka oil is lipophilic and cannot be diluted in aqueous cell culture media [<a href="#B69-pharmaceuticals-13-00343">69</a>], it is possible the actual concentration of mÄ�nuka oil in contact with the HUVEC cultures was significantly less than assumed.</p> <p>No signs of toxicity were observed on treatment with 10% active aqueous or oily phase of the cosmetic formulation for Campo MÄ�nuka Oil Extract in fibroblast cells. In vitro organogenesis assay (Living Dermal Matrix (LDM)), a toxicity assay that closely mimics the effect of a substance on human skin, consists of skin cells in a 3D-construct made of collagen. The LDM test proved Campo MÄ�nuka oil to be non-irritant with 99.4% cell viability after treatment with an undiluted sample in comparison to 100% propylene glycol (73%; a non-irritant) and 100% morpholine (6%; a moderate irritant) [<a href="#B73-pharmaceuticals-13-00343">73</a>]. </p> <p>Unpublished data showed gel formulations containing &amp;gt;10% mÄ�nuka oil did not induce acute skin sensitivity in mice (unpublished data Phytomed Medicinal Herbs Ltd.). Acute toxicity was not observed (LD<sub>50</sub> = 4612 g/kg) in mice after single oral administration of varying doses (500 mg/kg to 5000 mg/kg) of a patented formulation containing a mix of <i>Leptospermum scoparium</i> and <i>Kunzea ericoides</i> essential oils. The same formulation did not induce erythema or edema 3 and 7 days after a skin irritation test in epilated rabbits treated with 0.5 g of the product. Absence of percutaneous irritation was also demonstrated after treatment with 0.1 mL of 10% emulsion of the combined oil product onto the eyes of rabbits treated up to 7 days [<a href="#B74-pharmaceuticals-13-00343">74</a>].</p> <p>Product safety report on MELORAâ"¢ MÄ�nuka oil (&amp;lt;5%) according to EC Regulation 1223/2009 detailed high skin tolerance and good cosmetic acceptability of the product. The formulation has a relatively high content of Î²-triketones, such as flavesone, isoleptospermone, leptospermone and grandiflorone. Acute toxicities based on the routes of administration were LD<sub>50</sub> = 1061 mg/kg body weight and LD<sub>50</sub> &amp;gt; 2000 mg/kg body weight for oral and dermal administration, respectively. No irritation was noted on testing the formulation on rabbit eye mucous membranes. There was no skin sensitization or genetic toxicity after a micronucleus test in TK6 Human lymphoblastoid cells and bacterial reverse mutation test in <i>Salmonella typhimurium</i> and <i>E. coli</i>. It is intended for external use, could cause irritations in the eye on direct contact and a patch test is suggested before use [<a href="#B6-pharmaceuticals-13-00343">6</a>]. </p> <p>The safety evaluations for Campoâ"¢ MÄ�nuka Oil Extract (10% concentrate in water or ceramide) formulation according to EC regulations described that the oil was non-toxic for dermal use and was edible in small quantities (oral LD<sub>50</sub> = &amp;gt;9000 mg/kg body weight) after testing in rats. The formulation was classified as a non-irritant based on tests in vivo and in healthy human subjects. Patch tests in 50 healthy human subjects at doses from 0.5% to 100% showed satisfactory tolerance with no significant irritation reactions [<a href="#B73-pharmaceuticals-13-00343">73</a>]. The irritation potential of a 10% solution of mÄ�nuka oil was tested on the chorio-allantoic membrane of chicken egg, using the Eyetex assay and Skintex assay. All three tests deemed the formulation as non-irritant. The product did not have any comedogenic effect on the skin, indicating that the product does not clog pores and is well tolerated on the skin [<a href="#B73-pharmaceuticals-13-00343">73</a>]. </p> <p>Manuka oil sample pre-registered by the ECHA (EC Number: 434-370-3) was found to have LD<sub>50</sub>: 1.061 mg/kg body weight (95% CI: 722â€"1.557) for oral administration and LD50 &amp;gt;2000 mg/kg body weight. Low scores for erythema and edema were determined for skin irritation and eye irritation tests in vivo. </p> <p>MÄ�nuka oil is an active ingredient in the TGA-listed product Kiwiherb Herbal Throat Spray (ARTG ID 337576), which contains a mixture of <i>Echinacea purpurea</i> (6%), honey (7%), mÄ�nuka oil (1 ÂµL/mL), <i>Macropiper excelsum</i> var. <i>excelsum</i> (7%), propolis tincture (0.09 Âµg/mL and <i>Thymus vulgaris</i> (5%). The formulation is accepted in Australia by TGA for oral administration to reduce or relieve cold, cough, dry throat, mild throat inflammation, itchy throat and pharyngitis [<a href="#B75-pharmaceuticals-13-00343">75</a>]. </p> </div> </div> <div class="3.futuredirections" title="sec"> <div class="title" tagx="title" title="title">
3. Future Directions</div> <p>MÄ�nuka oil has been extensively used in traditional medicinal preparations and its individual fractions, particularly <i>Î²</i>-triketone constituents, exhibit many bioactive properties. Yet its application in clinical medicine remains under explored. The emergence of new strains of pathogens, including bacteria, viruses, parasites and fungi, coupled with the continued rise in antibiotic resistance, warrants further study of the potential antimicrobial activity of essential oils as therapeutic agents for their control and eradication. In contrast to tea tree oil, there is limited evidence on the efficacy and safety of mÄ�nuka oil in terms of geographic origin, parts of the plant used, dilutions and variation among formulations. The elucidated mechanisms of action exerted by topical application of mÄ�nuka oil are general to those of essential oils. Further reproducible studies looking into the mechanistic and lethal action of mÄ�nuka oil as well as its fractions are required to accurately compare efficacy between formulations and sources of the oil. Future studies on the synergistic efficacy of mÄ�nuka oil with synthetic drugs or other essential oils could improve its efficacy against pathogen, for instance Gram negative bacteria. In vivo studies on the medicinal properties of mÄ�nuka oil could inform therapeutic and interventional clinical trials. Additionally, there is a clear need for standardization of manuka oil (e.g., the International Organization for Standardization [ISO] and Association FranÃ§aise de Normalization [AFNOR] for quality specification of key bioactive terpene components) to meet the growing needs of therapeutic grade product.</p> </div> <div class="conclusions" title="conclusions"> <div class="title" tagx="title" title="title">
4. Conclusions</div> <p>With emerging resistance to drug-based antimicrobial and anti-parasitic treatments, as well as a growing interest in alternative therapies, the extensive in vitro data supporting the medicinal properties of mÄ�nuka oil warrant further clinical studies to characterize its true therapeutic benefits. Commercialization and therapeutic application of mÄ�nuka oil requires extensive regulation and standardization of the oil and clinical evidence for its medicinal properties. The review highlights an underutilized essential oil with potential medical applications similar to tea tree oil and mÄ�nuka honey. Further characterization of antimicrobial activity of manuka oil will clearly improve its potential to become a clinically useful product. The current in vitro data suggest that manuka oil products may have efficacy in the treatment of many cutaneous skin infections. These data also provide a sound basis from which to proceed to in vivo and clinical workâ€"which is critical in translating early laboratory findings into clinically useful outcomes.</p> <p>Since the mechanism of action has implications for the selectivity and safety of antimicrobial agents, this issue is becoming increasingly important. Despite growing interest in the oil for therapeutic purposes, the current data remains limited, highlighting the need for further research to understand how manuka oil works. There is enormous potential to expand the manuka oil industry if claims about its medicinal properties are to be verified. Scientific validation regarding the antimicrobial activity of manuka oil may assist in accessing of international markets and the registration of the oil with national regulatory bodies. </p> </div> </div> <div class="back" title="back"> <div class="ack" title="ack"> <div class="title" tagx="title" title="title">
Acknowledgments</div> <p>This work was supported by Faculty of Health, University of Canberra and Phytomed Medicinal Herbs Ltd., New Zealand.</p> </div> <div class="fn-group" title="fn-group"> <div class="fn-type-" title=""> <p><b>Publisherâ€™s Note:</b> MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p> </div> </div> <div class="title" tagx="title" title="title">
Author Contributions</div> <p>C.M.: Writing-Original draft and table preparation. W.T., G.M.P., A.B., and M.S.: Reviewing and Editing. P.R.: Reviewing and Editing. J.T.: Conceptualization, editing, reviewing and Supervision. All authors have read and agreed to the published version of the manuscript.</p> <div class="title" tagx="title" title="title">
Funding</div> <p>The review did not receive any external funding.</p> <div class="title" tagx="title" title="title">
Conflicts of Interest</div> <p>Authors declare no conflict of interest.</p> <div class="glossary" title="glossary"> <div class="title" tagx="title" title="title">
Abbreviations</div><span class="array" tagx="array" title="array">   ECHA European Chemicals Agency   MIC Minimum inhibitory concentrations   MBC Minimum Bactericidal Concentration   EINECS European Inventory of Existing Commercial chemical Substances   % <i>v/v</i> volume per volume   VRE vancomycin-resistant <i>Enterococcus faecalis</i>   MRSA methicillin-resistant <i>S. aureus</i>   ATCC American Type Culture Collection   EDTA Ethylenediaminetetraacetic acid   LC<sub>50</sub> lethal concentration required to kill 50% of the parasites   LD<sub>50</sub> dose required to kill half the members of a tested population after a specified test duration   LPS lipopolysaccharide   TNF-Î± Tumor necrosis factor alpha   IL Interleukin   UV ultraviolet   HSV Herpes simplex virus   IC<sub>50</sub> half maximal inhibitory concentration   US United States of America   EU European Union   CTFA Cosmetic, Toiletry and Fragrance Association   HUVEC human umbilical vein endothelial cells   LDM Living Dermal Matrix   3D three-dimensional   ARTG Australian Register of Therapeutic Goods.  </span></div> <div class="app-group" title="app-group"> <div class="app" title="app"> <div class="title" tagx="title" title="title">
Appendix A</div> <div class="table-wrap_UNKNOWN" id="pharmaceuticals-13-00343-t0A1" orientation="portrait" position="anchor">
pharmaceuticals-13-00343-t0A1_Table A1<span class="label" tagx="label" title="label">Table A1</span> <p>Search Strategy for PubMed and Embase (Via Scopus).</p>  <table frame="hsides" rules="groups"> <thead> <tr> <th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">PubMed</th> <th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Search Strategies </th> </tr> </thead> <tbody> <tr> <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">#1</td> <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(â€œleptospermumâ€�[MeSH Terms] OR â€œleptospermumâ€�[All Fields]) OR â€œleptospermums scopariumâ€�[All Fields]) OR (â€œmanukaâ€�[All Fields] AND â€œoilâ€�[All Fields])) OR ((â€œtea tree oilâ€�[MeSH Terms] OR â€œtea tree oilâ€�[All Fields] NOT (honey) [All Fields])</td> </tr> <tr> <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">#2</td> <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">((â€œantifungalâ€�[All Fields]) OR ((((((â€œanti-infective agentsâ€� OR â€œanti-infective agentsâ€�[MeSH Terms]) OR â€œanti-infective agentsâ€�[All Fields]) OR â€œantimicrobialâ€�[All Fields]) OR â€œanti-microbialâ€�[All Fields]) OR â€œantimicrobialsâ€�[All Fields] OR anti-inflammatory OR anti-inflammatory OR antiviral OR anti-viral OR â€œanti-viral agentsâ€�))</td> </tr> <tr> <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">#3</td> <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">#1 AND #2</td> </tr> <tr> <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><b>Embase (via Scopus)</b></td> <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" /> </tr> <tr> <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">#1</td> <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">leptospermum OR â€œleptospermums scopariumâ€� OR â€œmanuka oilâ€� OR â€œtea tree oilâ€� OR â€œtea treeâ€� NOT â€œhoneyâ€�</td> </tr> <tr> <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">#2</td> <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">â€œanti-infective agentsâ€� OR antibacterial OR â€œantibacterial agentâ€� OR â€œanti-infective agentsâ€� OR â€œanti-infective agentsâ€� OR â€œantimicrobialâ€� OR â€œanti-microbialâ€� OR â€œantimicrobialsâ€� OR anti-inflammatory OR anti-inflammatory OR antiviral OR anti-viral OR â€œanti-viral agentsâ€�</td> </tr> <tr> <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">#3</td> <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">#1 AND #2 </td> </tr> </tbody> </table> </div> </div> </div> <div class="references">
References</div> <div tag="ref-list"> <ul> <div class="title" tagx="title" title="title">
References</div> <li tag="ref"><a name="B1-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">1.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wilson</span><span class="given-names" tagx="given-names" title="given-names">P.G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Oâ€™Brien</span><span class="given-names" tagx="given-names" title="given-names">M.M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gadek</span><span class="given-names" tagx="given-names" title="given-names">P.A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Quinn</span><span class="given-names" tagx="given-names" title="given-names">C.J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Quinn</span><span class="given-names" tagx="given-names" title="given-names">P.A.G.J.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Myrtaceae revisited: A reassessment of infrafamilial groups</span><span class="source" tagx="source" title="source">Am. J. Bot.</span><span class="year" tagx="year" title="year">2001</span><span class="volume" tagx="volume" title="volume">88</span><span class="fpage" tagx="fpage" title="fpage">2013</span><span class="lpage" tagx="lpage" title="lpage">2025</span><span class="pub-id"><a href="https://dx.doi.org/10.2307/3558428">10.2307/3558428</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21669634">21669634</a></span></span></li> <li tag="ref"><a name="B2-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">2.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Maddocks-Jennings</span><span class="given-names" tagx="given-names" title="given-names">W.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wilkinson</span><span class="given-names" tagx="given-names" title="given-names">J.M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cavanagh</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shillington</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Evaluating the effects of the essential oils Leptospermum scoparium (manuka) and Kunzea ericoides (kanuka) on radiotherapy induced mucositis: A randomized, placebo controlled feasibility study</span><span class="source" tagx="source" title="source">Eur. J. Oncol. Nurs.</span><span class="year" tagx="year" title="year">2009</span><span class="volume" tagx="volume" title="volume">13</span><span class="fpage" tagx="fpage" title="fpage">87</span><span class="lpage" tagx="lpage" title="lpage">93</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.ejon.2009.01.002">10.1016/j.ejon.2009.01.002</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19297246">19297246</a></span></span></li> <li tag="ref"><a name="B3-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">3.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Carson</span><span class="given-names" tagx="given-names" title="given-names">C.F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Riley</span><span class="given-names" tagx="given-names" title="given-names">T.V.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Safety, efficacy and provenance of tea tree (Melaleuca alternifolia) oil</span><span class="source" tagx="source" title="source">Contact Dermat.</span><span class="year" tagx="year" title="year">2001</span><span class="volume" tagx="volume" title="volume">45</span><span class="fpage" tagx="fpage" title="fpage">65</span><span class="lpage" tagx="lpage" title="lpage">67</span><span class="pub-id"><a href="https://dx.doi.org/10.1034/j.1600-0536.2001.045002065.x">10.1034/j.1600-0536.2001.045002065.x</a></span></span></li> <li tag="ref"><a name="B4-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">4.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Avonto</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chittiboyina</span><span class="given-names" tagx="given-names" title="given-names">A.G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Vasquez</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rua</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">A Khan</span><span class="given-names" tagx="given-names" title="given-names">I.</span></span></span><span class="mixed-article-title" title="mixed-article-title">In Chemico Evaluation of Tea Tree Essential Oils as Skin Sensitizers: Impact of the Chemical Composition on Aging and Generation of Reactive Species</span><span class="source" tagx="source" title="source">Chem. Res. Toxicol.</span><span class="year" tagx="year" title="year">2016</span><span class="volume" tagx="volume" title="volume">29</span><span class="fpage" tagx="fpage" title="fpage">1108</span><span class="lpage" tagx="lpage" title="lpage">1117</span><span class="pub-id"><a href="https://dx.doi.org/10.1021/acs.chemrestox.5b00530">10.1021/acs.chemrestox.5b00530</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/27286037">27286037</a></span></span></li> <li tag="ref"><a name="B5-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">5.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Broadsheet</span><span class="given-names" tagx="given-names" title="given-names">C.F.R.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Essential Oil Production from Manuka &amp;amp; Kanuka</span><span class="comment">Available online: <a href="https://tararuacropping.files.wordpress.com/2016/08/essential-oil-manuka-may-2014_kanuka.pdf">https://tararuacropping.files.wordpress.com/2016/08/essential-oil-manuka-may-2014_kanuka.pdf</a></span><span class="date-in-citation" tagx="date-in-citation" title="date-in-citation">(accessed on 20 June 2020)</span></span></li> <li tag="ref"><a name="B6-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">6.</span><span class="element-citation'"><span class="person-group'"><span class="collab'">collab: Melora</span></span><span class="source" tagx="source" title="source">Cosmetic Product Safety Report: MELORAâ"¢ MÄ�nuka Oil</span><span class="publisher-name" tagx="publisher-name" title="publisher-name">Melora</span><span class="publisher-loc" tagx="publisher-loc" title="publisher-loc">Dublin, Ireland</span><span class="year" tagx="year" title="year">2017</span></span></li> <li tag="ref"><a name="B7-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">7.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Christoph</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kubeczka</span><span class="given-names" tagx="given-names" title="given-names">K.-H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Stahl-Biskup</span><span class="given-names" tagx="given-names" title="given-names">E.</span></span></span><span class="mixed-article-title" title="mixed-article-title">The Composition of Commercial Manuka Oils from New Zealand</span><span class="source" tagx="source" title="source">J. Essent. Oil Res.</span><span class="year" tagx="year" title="year">1999</span><span class="volume" tagx="volume" title="volume">11</span><span class="fpage" tagx="fpage" title="fpage">705</span><span class="lpage" tagx="lpage" title="lpage">710</span><span class="pub-id"><a href="https://dx.doi.org/10.1080/10412905.1999.9712001">10.1080/10412905.1999.9712001</a></span></span></li> <li tag="ref"><a name="B8-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">8.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Seyedalikhani</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Esperschuetz</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dickinson</span><span class="given-names" tagx="given-names" title="given-names">N.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hofmann</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Breitmeyer</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Horswell</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Robinson</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Biowastes to augment the essential oil production of Leptospermum scoparium and Kunzea robusta in low-fertility soil</span><span class="source" tagx="source" title="source">Plant Physiol. Biochem.</span><span class="year" tagx="year" title="year">2019</span><span class="volume" tagx="volume" title="volume">137</span><span class="fpage" tagx="fpage" title="fpage">213</span><span class="lpage" tagx="lpage" title="lpage">221</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.plaphy.2019.02.008">10.1016/j.plaphy.2019.02.008</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30802804">30802804</a></span></span></li> <li tag="ref"><a name="B9-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">9.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Porter</span><span class="given-names" tagx="given-names" title="given-names">N.G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Smale</span><span class="given-names" tagx="given-names" title="given-names">P.E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nelson</span><span class="given-names" tagx="given-names" title="given-names">M.A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hay</span><span class="given-names" tagx="given-names" title="given-names">A.J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Van Klink</span><span class="given-names" tagx="given-names" title="given-names">J.W.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dean</span><span class="given-names" tagx="given-names" title="given-names">C.M.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Variability in essential oil chemistry and plant morphology within aLeptospermum scopariumpopulation</span><span class="source" tagx="source" title="source">N. Z. J. Bot.</span><span class="year" tagx="year" title="year">1998</span><span class="volume" tagx="volume" title="volume">36</span><span class="fpage" tagx="fpage" title="fpage">125</span><span class="lpage" tagx="lpage" title="lpage">133</span><span class="pub-id"><a href="https://dx.doi.org/10.1080/0028825X.1998.9512551">10.1080/0028825X.1998.9512551</a></span></span></li> <li tag="ref"><a name="B10-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">10.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Porter</span><span class="given-names" tagx="given-names" title="given-names">N.G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wilkins</span><span class="given-names" tagx="given-names" title="given-names">A.L.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Chemical, physical and antimicrobial properties of essential oils of Leptospermum scoparium and Kunzea ericoides</span><span class="source" tagx="source" title="source">Phytochemistry</span><span class="year" tagx="year" title="year">1999</span><span class="volume" tagx="volume" title="volume">50</span><span class="fpage" tagx="fpage" title="fpage">407</span><span class="lpage" tagx="lpage" title="lpage">415</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/S0031-9422(98)00548-2">10.1016/S0031-9422(98)00548-2</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/9933953">9933953</a></span></span></li> <li tag="ref"><a name="B11-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">11.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Douglas</span><span class="given-names" tagx="given-names" title="given-names">M.H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Van Klink</span><span class="given-names" tagx="given-names" title="given-names">J.W.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Smallfield</span><span class="given-names" tagx="given-names" title="given-names">B.M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Perry</span><span class="given-names" tagx="given-names" title="given-names">N.B.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Anderson</span><span class="given-names" tagx="given-names" title="given-names">R.E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Johnstone</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Weavers</span><span class="given-names" tagx="given-names" title="given-names">R.T.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Essential oils from New Zealand manuka: Triketone and other chemotypes of Leptospermum scoparium</span><span class="source" tagx="source" title="source">Phytochemistry</span><span class="year" tagx="year" title="year">2004</span><span class="volume" tagx="volume" title="volume">65</span><span class="fpage" tagx="fpage" title="fpage">1255</span><span class="lpage" tagx="lpage" title="lpage">1264</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.phytochem.2004.03.019">10.1016/j.phytochem.2004.03.019</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/15184010">15184010</a></span></span></li> <li tag="ref"><a name="B12-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">12.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Christoph</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kaulfers</span><span class="given-names" tagx="given-names" title="given-names">P.M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Stahl-Biskup</span><span class="given-names" tagx="given-names" title="given-names">E.</span></span></span><span class="mixed-article-title" title="mixed-article-title">In vitro evaluation of the antibacterial activity of Î²-triketones admixed to Melaleuca oils</span><span class="source" tagx="source" title="source">Planta Med.</span><span class="year" tagx="year" title="year">2001</span><span class="volume" tagx="volume" title="volume">67</span><span class="fpage" tagx="fpage" title="fpage">768</span><span class="lpage" tagx="lpage" title="lpage">771</span><span class="pub-id"><a href="https://dx.doi.org/10.1055/s-2001-18350">10.1055/s-2001-18350</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11731927">11731927</a></span></span></li> <li tag="ref"><a name="B13-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">13.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Christoph</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Stahl-Biskup</span><span class="given-names" tagx="given-names" title="given-names">E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kaulfers</span><span class="given-names" tagx="given-names" title="given-names">P.M.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Death Kinetics of Staphylococcus aureus Exposed to Commercial Tea Tree Oils s.l</span><span class="source" tagx="source" title="source">J. Essent. Oil Res.</span><span class="year" tagx="year" title="year">2001</span><span class="volume" tagx="volume" title="volume">13</span><span class="fpage" tagx="fpage" title="fpage">98</span><span class="lpage" tagx="lpage" title="lpage">102</span><span class="pub-id"><a href="https://dx.doi.org/10.1080/10412905.2001.9699625">10.1080/10412905.2001.9699625</a></span></span></li> <li tag="ref"><a name="B14-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">14.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Fang</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Candy</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Melloul</span><span class="given-names" tagx="given-names" title="given-names">E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bernigaud</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chai</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Darmon</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Durand</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Botterel</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chosidow</span><span class="given-names" tagx="given-names" title="given-names">O.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Izri</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">In vitro activity of ten essential oils against Sarcoptes scabiei</span><span class="source" tagx="source" title="source">Parasites Vectors</span><span class="year" tagx="year" title="year">2016</span><span class="volume" tagx="volume" title="volume">9</span><span class="fpage" tagx="fpage" title="fpage">1</span><span class="lpage" tagx="lpage" title="lpage">7</span><span class="pub-id"><a href="https://dx.doi.org/10.1186/s13071-016-1889-3">10.1186/s13071-016-1889-3</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/26728523">26728523</a></span></span></li> <li tag="ref"><a name="B15-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">15.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Killeen</span><span class="given-names" tagx="given-names" title="given-names">D.P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Van Klink</span><span class="given-names" tagx="given-names" title="given-names">J.W.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Smallfield</span><span class="given-names" tagx="given-names" title="given-names">B.M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gordon</span><span class="given-names" tagx="given-names" title="given-names">K.C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Perry</span><span class="given-names" tagx="given-names" title="given-names">N.B.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Herbicidal Î²-triketones are compartmentalized in leaves of Leptospermumspecies: Localization by Raman microscopy and rapid screening</span><span class="source" tagx="source" title="source">New Phytol.</span><span class="year" tagx="year" title="year">2015</span><span class="volume" tagx="volume" title="volume">205</span><span class="fpage" tagx="fpage" title="fpage">339</span><span class="lpage" tagx="lpage" title="lpage">349</span><span class="pub-id"><a href="https://dx.doi.org/10.1111/nph.12970">10.1111/nph.12970</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/25103692">25103692</a></span></span></li> <li tag="ref"><a name="B16-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">16.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Perry</span><span class="given-names" tagx="given-names" title="given-names">N.B.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Brennan</span><span class="given-names" tagx="given-names" title="given-names">N.J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Van Klink</span><span class="given-names" tagx="given-names" title="given-names">J.W.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Harris</span><span class="given-names" tagx="given-names" title="given-names">W.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Douglas</span><span class="given-names" tagx="given-names" title="given-names">M.H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">McGimpsey</span><span class="given-names" tagx="given-names" title="given-names">J.A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Smallfield</span><span class="given-names" tagx="given-names" title="given-names">B.M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Anderson</span><span class="given-names" tagx="given-names" title="given-names">R.E.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Essential oils from New Zealand manuka and kanuka: Chemotaxonomy of Leptospermum</span><span class="source" tagx="source" title="source">Phytochemistry</span><span class="year" tagx="year" title="year">1997</span><span class="volume" tagx="volume" title="volume">44</span><span class="fpage" tagx="fpage" title="fpage">1485</span><span class="lpage" tagx="lpage" title="lpage">1494</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/S0031-9422(96)00743-1">10.1016/S0031-9422(96)00743-1</a></span></span></li> <li tag="ref"><a name="B17-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">17.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Perry</span><span class="given-names" tagx="given-names" title="given-names">N.B.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Van Klink</span><span class="given-names" tagx="given-names" title="given-names">J.W.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Brennan</span><span class="given-names" tagx="given-names" title="given-names">N.J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Harris</span><span class="given-names" tagx="given-names" title="given-names">W.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Anderson</span><span class="given-names" tagx="given-names" title="given-names">R.E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Douglas</span><span class="given-names" tagx="given-names" title="given-names">M.H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Smallfield</span><span class="given-names" tagx="given-names" title="given-names">B.M.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Essential oils from new zealand manuka and kanuka: Chemotaxonomy of kunzea</span><span class="source" tagx="source" title="source">Phytochemistry</span><span class="year" tagx="year" title="year">1997</span><span class="volume" tagx="volume" title="volume">45</span><span class="fpage" tagx="fpage" title="fpage">1605</span><span class="lpage" tagx="lpage" title="lpage">1612</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/S0031-9422(97)00203-3">10.1016/S0031-9422(97)00203-3</a></span></span></li> <li tag="ref"><a name="B18-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">18.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dayan</span><span class="given-names" tagx="given-names" title="given-names">F.E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Howell</span><span class="given-names" tagx="given-names" title="given-names">J.L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Marais</span><span class="given-names" tagx="given-names" title="given-names">J.P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ferreira</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Koivunen</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Manuka Oil, A Natural Herbicide with Preemergence Activity</span><span class="source" tagx="source" title="source">Weed Sci.</span><span class="year" tagx="year" title="year">2011</span><span class="volume" tagx="volume" title="volume">59</span><span class="fpage" tagx="fpage" title="fpage">464</span><span class="lpage" tagx="lpage" title="lpage">469</span><span class="pub-id"><a href="https://dx.doi.org/10.1614/WS-D-11-00043.1">10.1614/WS-D-11-00043.1</a></span></span></li> <li tag="ref"><a name="B19-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">19.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jeong</span><span class="given-names" tagx="given-names" title="given-names">E.Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jeon</span><span class="given-names" tagx="given-names" title="given-names">J.H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kim</span><span class="given-names" tagx="given-names" title="given-names">H.W.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kim</span><span class="given-names" tagx="given-names" title="given-names">M.G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lee</span><span class="given-names" tagx="given-names" title="given-names">H.S.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Antimicrobial activity of leptospermone and its derivatives against human intestinal bacteria</span><span class="source" tagx="source" title="source">Food Chem.</span><span class="year" tagx="year" title="year">2009</span><span class="volume" tagx="volume" title="volume">115</span><span class="fpage" tagx="fpage" title="fpage">1401</span><span class="lpage" tagx="lpage" title="lpage">1404</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.foodchem.2009.01.086">10.1016/j.foodchem.2009.01.086</a></span></span></li> <li tag="ref"><a name="B20-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">20.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jeong</span><span class="given-names" tagx="given-names" title="given-names">E.Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kim</span><span class="given-names" tagx="given-names" title="given-names">M.G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lee</span><span class="given-names" tagx="given-names" title="given-names">H.S.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Acaricidal activity of triketone analogues derived fromLeptospermum scopariumoil against house-dust and stored-food mites</span><span class="source" tagx="source" title="source">Pest Manag. Sci.</span><span class="year" tagx="year" title="year">2009</span><span class="volume" tagx="volume" title="volume">65</span><span class="fpage" tagx="fpage" title="fpage">327</span><span class="lpage" tagx="lpage" title="lpage">331</span><span class="pub-id"><a href="https://dx.doi.org/10.1002/ps.1684">10.1002/ps.1684</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19051215">19051215</a></span></span></li> <li tag="ref"><a name="B21-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">21.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Muturi</span><span class="given-names" tagx="given-names" title="given-names">E.J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Selling</span><span class="given-names" tagx="given-names" title="given-names">G.W.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Doll</span><span class="given-names" tagx="given-names" title="given-names">K.M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hay</span><span class="given-names" tagx="given-names" title="given-names">W.T.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ramirez</span><span class="given-names" tagx="given-names" title="given-names">J.L.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Leptospermum scoparium essential oil is a promising source of mosquito larvicide and its toxicity is enhanced by a biobased emulsifier</span><span class="source" tagx="source" title="source">PLoS ONE</span><span class="year" tagx="year" title="year">2020</span><span class="volume" tagx="volume" title="volume">15</span><span class="elocation-id" tagx="elocation-id" title="elocation-id">e229076</span><span class="pub-id"><a href="https://dx.doi.org/10.1371/journal.pone.0229076">10.1371/journal.pone.0229076</a></span></span></li> <li tag="ref"><a name="B22-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">22.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Govindarajan</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rajeswary</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Benelli</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Î´-Cadinene, Calarene and Î´-4-Carene from Kadsura heteroclita Essential Oil as Novel Larvicides Against Malaria, Dengue and Filariasis Mosquitoes</span><span class="source" tagx="source" title="source">Comb. Chem. High Throughput Screen.</span><span class="year" tagx="year" title="year">2016</span><span class="volume" tagx="volume" title="volume">19</span><span class="fpage" tagx="fpage" title="fpage">565</span><span class="lpage" tagx="lpage" title="lpage">571</span><span class="pub-id"><a href="https://dx.doi.org/10.2174/1386207319666160506123520">10.2174/1386207319666160506123520</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/27151483">27151483</a></span></span></li> <li tag="ref"><a name="B23-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">23.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Reichling</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Koch</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Stahl-Biskup</span><span class="given-names" tagx="given-names" title="given-names">E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sojka</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Schnitzler</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Virucidal Activity of a Î²-Triketone-Rich Essential Oil ofLeptospermum scoparium (Manuka Oil) Against HSV-1 and HSV-2 in Cell Culture</span><span class="source" tagx="source" title="source">Planta Med.</span><span class="year" tagx="year" title="year">2005</span><span class="volume" tagx="volume" title="volume">71</span><span class="fpage" tagx="fpage" title="fpage">1123</span><span class="lpage" tagx="lpage" title="lpage">1127</span><span class="pub-id"><a href="https://dx.doi.org/10.1055/s-2005-873175">10.1055/s-2005-873175</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/16395648">16395648</a></span></span></li> <li tag="ref"><a name="B24-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">24.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shelly</span><span class="given-names" tagx="given-names" title="given-names">T.E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cowan</span><span class="given-names" tagx="given-names" title="given-names">A.N.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Edu</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pahio</span><span class="given-names" tagx="given-names" title="given-names">E.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Mating success of male Mediterranean fruit flies following exposure to two sources of alpha-copaene, manuka oil and mango</span><span class="source" tagx="source" title="source">Fla. Entomol.</span><span class="year" tagx="year" title="year">2008</span><span class="volume" tagx="volume" title="volume">91</span><span class="fpage" tagx="fpage" title="fpage">9</span><span class="lpage" tagx="lpage" title="lpage">15</span><span class="pub-id"><a href="https://dx.doi.org/10.1653/0015-4040(2008)091[0009:MSOMMF]2.0.CO;2">10.1653/0015-4040(2008)091[0009:MSOMMF]2.0.CO;2</a></span></span></li> <li tag="ref"><a name="B25-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">25.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hanula</span><span class="given-names" tagx="given-names" title="given-names">J.L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mayfield</span><span class="given-names" tagx="given-names" title="given-names">A.E.</span><span class="suffix" tagx="suffix" title="suffix">III</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Reid</span><span class="given-names" tagx="given-names" title="given-names">L.S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Horn</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Influence of trap distance from a source population and multiple traps on captures and attack densities of the redbay ambrosia beetle (Coleoptera: Curculionidae: Scolytinae)</span><span class="source" tagx="source" title="source">J. Econol. Entomol.</span><span class="year" tagx="year" title="year">2016</span><span class="volume" tagx="volume" title="volume">109</span><span class="fpage" tagx="fpage" title="fpage">1196</span><span class="lpage" tagx="lpage" title="lpage">1204</span><span class="pub-id"><a href="https://dx.doi.org/10.1093/jee/tow068">10.1093/jee/tow068</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/27053703">27053703</a></span></span></li> <li tag="ref"><a name="B26-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">26.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kong</span><span class="given-names" tagx="given-names" title="given-names">Q.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">An</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Qi</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yu</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lu</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ren</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Antifungal mechanisms of Î±-terpineol and terpene-4-alcohol as the critical components of Melaleuca alternifolia oil in the inhibition of rot disease caused by Aspergillus ochraceus in postharvest grapes</span><span class="source" tagx="source" title="source">J. Appl. Microbiol.</span><span class="year" tagx="year" title="year">2019</span><span class="volume" tagx="volume" title="volume">126</span><span class="fpage" tagx="fpage" title="fpage">1161</span><span class="lpage" tagx="lpage" title="lpage">1174</span><span class="pub-id"><a href="https://dx.doi.org/10.1111/jam.14193">10.1111/jam.14193</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30614164">30614164</a></span></span></li> <li tag="ref"><a name="B27-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">27.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nogueira</span><span class="given-names" tagx="given-names" title="given-names">M.N.M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Aquino</span><span class="given-names" tagx="given-names" title="given-names">S.G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rossa Junior</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Spolidorio</span><span class="given-names" tagx="given-names" title="given-names">D.M.P.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Terpinen-4-ol and alpha-terpineol (tea tree oil components) inhibit the production of IL-1Î², IL-6 and IL-10 on human macrophages</span><span class="source" tagx="source" title="source">Inflamm. Res.</span><span class="year" tagx="year" title="year">2014</span><span class="volume" tagx="volume" title="volume">63</span><span class="fpage" tagx="fpage" title="fpage">769</span><span class="lpage" tagx="lpage" title="lpage">778</span><span class="pub-id"><a href="https://dx.doi.org/10.1007/s00011-014-0749-x">10.1007/s00011-014-0749-x</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/24947163">24947163</a></span></span></li> <li tag="ref"><a name="B28-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">28.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lis-Balchin</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hart</span><span class="given-names" tagx="given-names" title="given-names">S.L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Deans</span><span class="given-names" tagx="given-names" title="given-names">S.G.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Pharmacological and antimicrobial studies on different tea-tree oils (Melaleuca alternifolia, Leptospermum scoparium or Manuka and Kunzea ericoides or Kanuka), originating in Australia and New Zealand</span><span class="source" tagx="source" title="source">Phytotherapy Res.</span><span class="year" tagx="year" title="year">2000</span><span class="volume" tagx="volume" title="volume">14</span><span class="fpage" tagx="fpage" title="fpage">623</span><span class="lpage" tagx="lpage" title="lpage">629</span><span class="pub-id"><a href="https://dx.doi.org/10.1002/1099-1573(200012)14:8&lt;623::AID-PTR763&gt;3.0.CO;2-Z">10.1002/1099-1573(200012)14:8&amp;lt;623::AID-PTR763&amp;gt;3.0.CO;2-Z</a></span></span></li> <li tag="ref"><a name="B29-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">29.</span><span class="element-citation'"><span class="mixed-article-title" title="mixed-article-title">Manuka Oil Beta Troketones. Manuka Essential Oil</span><span class="comment">Available online: <a href="http://www.mbtk.org.nz/what-msstk/manuka-essential-oil/">http://www.mbtk.org.nz/what-msstk/manuka-essential-oil/</a></span><span class="date-in-citation" tagx="date-in-citation" title="date-in-citation">(accessed on 23 June 2020)</span></span></li> <li tag="ref"><a name="B30-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">30.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Christoph</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kaulfers</span><span class="given-names" tagx="given-names" title="given-names">P.-M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Stahl-Biskup</span><span class="given-names" tagx="given-names" title="given-names">E.</span></span></span><span class="mixed-article-title" title="mixed-article-title">A Comparative Study of the in vitro Antimicrobial Activity of Tea Tree Oils s.l. with Special Reference to the Activity of Î²-Triketones</span><span class="source" tagx="source" title="source">Planta Med.</span><span class="year" tagx="year" title="year">2000</span><span class="volume" tagx="volume" title="volume">66</span><span class="fpage" tagx="fpage" title="fpage">556</span><span class="lpage" tagx="lpage" title="lpage">560</span><span class="pub-id"><a href="https://dx.doi.org/10.1055/s-2000-8604">10.1055/s-2000-8604</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/10985085">10985085</a></span></span></li> <li tag="ref"><a name="B31-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">31.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Van Vuuren</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Docrat</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kamatou</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Viljoen</span><span class="given-names" tagx="given-names" title="given-names">A.M.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Essential oil composition and antimicrobial interactions of understudied tea tree species</span><span class="source" tagx="source" title="source">S. Afr. J. Bot.</span><span class="year" tagx="year" title="year">2014</span><span class="volume" tagx="volume" title="volume">92</span><span class="fpage" tagx="fpage" title="fpage">7</span><span class="lpage" tagx="lpage" title="lpage">14</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.sajb.2014.01.005">10.1016/j.sajb.2014.01.005</a></span></span></li> <li tag="ref"><a name="B32-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">32.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bent</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Herbal Medicine in the United States: Review of Efficacy, Safety, and Regulation: Grand Rounds at University of California, San Francisco Medical Center</span><span class="source" tagx="source" title="source">J. Gen. Intern. Med.</span><span class="year" tagx="year" title="year">2008</span><span class="volume" tagx="volume" title="volume">23</span><span class="fpage" tagx="fpage" title="fpage">854</span><span class="lpage" tagx="lpage" title="lpage">859</span><span class="pub-id"><a href="https://dx.doi.org/10.1007/s11606-008-0632-y">10.1007/s11606-008-0632-y</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18415652">18415652</a></span></span></li> <li tag="ref"><a name="B33-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">33.</span><span class="element-citation'"><span class="mixed-article-title" title="mixed-article-title">MÄ�ori Medicine</span><span class="comment">Available online: <a href="https://www.tepapa.govt.nz/discover-collections/read-watch-play/maori/maori-medicine">https://www.tepapa.govt.nz/discover-collections/read-watch-play/maori/maori-medicine</a></span><span class="date-in-citation" tagx="date-in-citation" title="date-in-citation">(accessed on 23 June 2020)</span></span></li> <li tag="ref"><a name="B34-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">34.</span><span class="element-citation'"><span class="mixed-article-title" title="mixed-article-title">Plant Use Details: Leptospermum scoparium. MÄ�nuka. Kahikatoa</span><span class="comment">Available online: <a href="https://maoriplantuse.landcareresearch.co.nz/WebForms/PeoplePlantsDetails.aspx?PKey=34969a5f-698d-437d-8a84-c71dd21351a5">https://maoriplantuse.landcareresearch.co.nz/WebForms/PeoplePlantsDetails.aspx?PKey=34969a5f-698d-437d-8a84-c71dd21351a5</a></span><span class="date-in-citation" tagx="date-in-citation" title="date-in-citation">(accessed on 23 June 2020)</span></span></li> <li tag="ref"><a name="B35-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">35.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Alnaimat</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wainwright</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jaber</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Amasha</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Mechanism of the Antibacterial Action of (Leptospermum scoparium) Oil on Methicillin-resistant Staphylococcus aureus (MRSA)and E. coli)</span><span class="source" tagx="source" title="source">Proceedings of the 2nd Mediterranean Symposium on Medicinal and Aromatic Plants (MESMAP-2)</span><span class="conf-loc" tagx="conf-loc" title="conf-loc">Antalya, Turkey</span><span class="conf-date" tagx="conf-date" title="conf-date">22â€"25 April 2015</span></span></li> <li tag="ref"><a name="B36-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">36.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Fratini</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mancini</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Turchi</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Friscia</span><span class="given-names" tagx="given-names" title="given-names">E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pistelli</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Giusti</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cerri</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span></span><span class="mixed-article-title" title="mixed-article-title">A novel interpretation of the Fractional Inhibitory Concentration Index: The case Origanum vulgare L. and Leptospermum scoparium J.R. et G. Forst essential oils against Staphylococcus aureus strains</span><span class="source" tagx="source" title="source">Microbiol. Res.</span><span class="year" tagx="year" title="year">2017</span><span class="volume" tagx="volume" title="volume">195</span><span class="fpage" tagx="fpage" title="fpage">11</span><span class="lpage" tagx="lpage" title="lpage">17</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.micres.2016.11.005">10.1016/j.micres.2016.11.005</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/28024521">28024521</a></span></span></li> <li tag="ref"><a name="B37-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">37.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chen</span><span class="given-names" tagx="given-names" title="given-names">C.C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yan</span><span class="given-names" tagx="given-names" title="given-names">S.H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yen</span><span class="given-names" tagx="given-names" title="given-names">M.Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wu</span><span class="given-names" tagx="given-names" title="given-names">P.F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liao</span><span class="given-names" tagx="given-names" title="given-names">W.T.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Huang</span><span class="given-names" tagx="given-names" title="given-names">T.S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wen</span><span class="given-names" tagx="given-names" title="given-names">Z.H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">H.M.D.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Investigations of kanuka and manuka essential oils for in vitro treatment of disease and cellular inflammation caused by infectious microorganisms</span><span class="source" tagx="source" title="source">J. Microbiol. Immunol. Infect.</span><span class="year" tagx="year" title="year">2016</span><span class="volume" tagx="volume" title="volume">49</span><span class="fpage" tagx="fpage" title="fpage">104</span><span class="lpage" tagx="lpage" title="lpage">111</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.jmii.2013.12.009">10.1016/j.jmii.2013.12.009</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/24582465">24582465</a></span></span></li> <li tag="ref"><a name="B38-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">38.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Takarada</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kimizuka</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Takahashi</span><span class="given-names" tagx="given-names" title="given-names">N.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Honma</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Okuda</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kato</span><span class="given-names" tagx="given-names" title="given-names">T.</span></span></span><span class="mixed-article-title" title="mixed-article-title">A comparison of the antibacterial efficacies of essential oils against oral pathogens</span><span class="source" tagx="source" title="source">Oral Microbiol. Immunol.</span><span class="year" tagx="year" title="year">2004</span><span class="volume" tagx="volume" title="volume">19</span><span class="fpage" tagx="fpage" title="fpage">61</span><span class="lpage" tagx="lpage" title="lpage">64</span><span class="pub-id"><a href="https://dx.doi.org/10.1046/j.0902-0055.2003.00111.x">10.1046/j.0902-0055.2003.00111.x</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/14678476">14678476</a></span></span></li> <li tag="ref"><a name="B39-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">39.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Song</span><span class="given-names" tagx="given-names" title="given-names">C.Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nam</span><span class="given-names" tagx="given-names" title="given-names">E.H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Park</span><span class="given-names" tagx="given-names" title="given-names">S.H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hwang</span><span class="given-names" tagx="given-names" title="given-names">C.Y.</span></span></span><span class="mixed-article-title" title="mixed-article-title">In vitroefficacy of the essential oil fromLeptospermum scoparium(manuka) on antimicrobial susceptibility and biofilm formation inStaphylococcus pseudintermediusisolates from dogs</span><span class="source" tagx="source" title="source">Veter Dermatol.</span><span class="year" tagx="year" title="year">2013</span><span class="volume" tagx="volume" title="volume">24</span><span class="fpage" tagx="fpage" title="fpage">404</span><span class="pub-id"><a href="https://dx.doi.org/10.1111/vde.12045">10.1111/vde.12045</a></span></span></li> <li tag="ref"><a name="B40-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">40.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Turchi</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mancini</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pistelli</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Najar</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Fratini</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Sub-inhibitory concentration of essential oils induces antibiotic resistance in Staphylococcus aureus</span><span class="source" tagx="source" title="source">Nat. Prod. Res.</span><span class="year" tagx="year" title="year">2019</span><span class="volume" tagx="volume" title="volume">33</span><span class="fpage" tagx="fpage" title="fpage">1509</span><span class="lpage" tagx="lpage" title="lpage">1513</span><span class="pub-id"><a href="https://dx.doi.org/10.1080/14786419.2017.1419237">10.1080/14786419.2017.1419237</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/29272983">29272983</a></span></span></li> <li tag="ref"><a name="B41-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">41.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Orchard</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Van Vuuren</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Viljoen</span><span class="given-names" tagx="given-names" title="given-names">A.M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kamatou</span><span class="given-names" tagx="given-names" title="given-names">G.P.P.</span></span></span><span class="mixed-article-title" title="mixed-article-title">The in vitro antimicrobial evaluation of commercial essential oils and their combinations against acne</span><span class="source" tagx="source" title="source">Int. J. Cosmet. Sci.</span><span class="year" tagx="year" title="year">2018</span><span class="volume" tagx="volume" title="volume">40</span><span class="fpage" tagx="fpage" title="fpage">226</span><span class="lpage" tagx="lpage" title="lpage">243</span><span class="pub-id"><a href="https://dx.doi.org/10.1111/ics.12456">10.1111/ics.12456</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/29574906">29574906</a></span></span></li> <li tag="ref"><a name="B42-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">42.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kim</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lee</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lee</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Joo</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Choe</span><span class="given-names" tagx="given-names" title="given-names">T.</span></span></span><span class="mixed-article-title" title="mixed-article-title">The effects of antimicrobial properties of manuka oil and improvement of acne</span><span class="source" tagx="source" title="source">J. Korean Soc. Cosmetol.</span><span class="year" tagx="year" title="year">2011</span><span class="volume" tagx="volume" title="volume">17</span><span class="fpage" tagx="fpage" title="fpage">245</span><span class="lpage" tagx="lpage" title="lpage">256</span></span></li> <li tag="ref"><a name="B43-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">43.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wu</span><span class="given-names" tagx="given-names" title="given-names">Q.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wu</span><span class="given-names" tagx="given-names" title="given-names">Q.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Antimicrobial Effect of Manuka Honey and Kanuka Honey Alone and in Combination with the Bioactives Against the Growth of Propionibacterium Acnes ATCC 6919</span><span class="source" tagx="source" title="source">Masterâ€™s Thesis</span><span class="publisher-name" tagx="publisher-name" title="publisher-name">Massey University</span><span class="publisher-loc" tagx="publisher-loc" title="publisher-loc">Auckland, New Zealand</span><span class="month" tagx="month" title="month">6</span><span class="year" tagx="year" title="year">2011</span></span></li> <li tag="ref"><a name="B44-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">44.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Prosser</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Anderson</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Horswell</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Speir</span><span class="given-names" tagx="given-names" title="given-names">T.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Can manuka (Leptospermum scoparium) antimicrobial properties be utilised in the remediation of pathogen contaminated land?</span><span class="source" tagx="source" title="source">Soil Biol. Biochem.</span><span class="year" tagx="year" title="year">2014</span><span class="volume" tagx="volume" title="volume">75</span><span class="fpage" tagx="fpage" title="fpage">167</span><span class="lpage" tagx="lpage" title="lpage">174</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.soilbio.2014.04.003">10.1016/j.soilbio.2014.04.003</a></span></span></li> <li tag="ref"><a name="B45-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">45.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Killeen</span><span class="given-names" tagx="given-names" title="given-names">D.P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Larsen</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dayan</span><span class="given-names" tagx="given-names" title="given-names">F.E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gordon</span><span class="given-names" tagx="given-names" title="given-names">K.C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Perry</span><span class="given-names" tagx="given-names" title="given-names">N.B.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Van Klink</span><span class="given-names" tagx="given-names" title="given-names">J.W.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Nortriketones: Antimicrobial Trimethylated Acylphloroglucinols from MÄ�nuka (Leptospermum scoparium)</span><span class="source" tagx="source" title="source">J. Nat. Prod.</span><span class="year" tagx="year" title="year">2016</span><span class="volume" tagx="volume" title="volume">79</span><span class="fpage" tagx="fpage" title="fpage">564</span><span class="lpage" tagx="lpage" title="lpage">569</span><span class="pub-id"><a href="https://dx.doi.org/10.1021/acs.jnatprod.5b00968">10.1021/acs.jnatprod.5b00968</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/26731565">26731565</a></span></span></li> <li tag="ref"><a name="B46-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">46.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bergonzelli</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Donnicola</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Porta</span><span class="given-names" tagx="given-names" title="given-names">N.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">CorthÃ©sy-TheulazI</span><span class="given-names" tagx="given-names" title="given-names">E.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Essential Oils as Components of a Diet-Based Approach to Management of Helicobacter Infection</span><span class="source" tagx="source" title="source">Antimicrob. Agents Chemother.</span><span class="year" tagx="year" title="year">2003</span><span class="volume" tagx="volume" title="volume">47</span><span class="fpage" tagx="fpage" title="fpage">3240</span><span class="lpage" tagx="lpage" title="lpage">3246</span><span class="pub-id"><a href="https://dx.doi.org/10.1128/AAC.47.10.3240-3246.2003">10.1128/AAC.47.10.3240-3246.2003</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/14506036">14506036</a></span></span></li> <li tag="ref"><a name="B47-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">47.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Schmolz</span><span class="given-names" tagx="given-names" title="given-names">E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Doebner</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Auste</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Daum</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Welge</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lamprecht</span><span class="given-names" tagx="given-names" title="given-names">I.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Bioenergetic investigations on tea-tree and related essential oils</span><span class="source" tagx="source" title="source">Thermochim. Acta</span><span class="year" tagx="year" title="year">1999</span><span class="volume" tagx="volume" title="volume">337</span><span class="fpage" tagx="fpage" title="fpage">71</span><span class="lpage" tagx="lpage" title="lpage">81</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/S0040-6031(99)00231-2">10.1016/S0040-6031(99)00231-2</a></span></span></li> <li tag="ref"><a name="B48-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">48.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Prosser</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Woods</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Horswell</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Robinson</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span></span><span class="mixed-article-title" title="mixed-article-title">The potential in-situ antimicrobial ability of Myrtaceae plant species on pathogens in soil</span><span class="source" tagx="source" title="source">Soil Biol. Biochem.</span><span class="year" tagx="year" title="year">2016</span><span class="volume" tagx="volume" title="volume">96</span><span class="fpage" tagx="fpage" title="fpage">1</span><span class="lpage" tagx="lpage" title="lpage">3</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.soilbio.2015.12.007">10.1016/j.soilbio.2015.12.007</a></span></span></li> <li tag="ref"><a name="B49-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">49.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jeong</span><span class="given-names" tagx="given-names" title="given-names">E.Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lee</span><span class="given-names" tagx="given-names" title="given-names">M.J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lee</span><span class="given-names" tagx="given-names" title="given-names">H.S.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Antimicrobial activities of leptospermone isolated from Leptospermum scoparium seeds and structure-activity relationships of its derivatives against foodborne bacteria</span><span class="source" tagx="source" title="source">Food Sci. Biotechnol.</span><span class="year" tagx="year" title="year">2018</span><span class="volume" tagx="volume" title="volume">27</span><span class="fpage" tagx="fpage" title="fpage">1541</span><span class="lpage" tagx="lpage" title="lpage">1547</span><span class="pub-id"><a href="https://dx.doi.org/10.1007/s10068-018-0391-4">10.1007/s10068-018-0391-4</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30319866">30319866</a></span></span></li> <li tag="ref"><a name="B50-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">50.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Song</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hyun</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kang</span><span class="given-names" tagx="given-names" title="given-names">J.H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hwang</span><span class="given-names" tagx="given-names" title="given-names">C.Y.</span></span></span><span class="mixed-article-title" title="mixed-article-title">In vitro antibacterial activity of the manuka essential oil from Leptospermum scoparium combined with Tris-EDTA against Gram-negative bacterial isolates from dogs with otitis externa</span><span class="source" tagx="source" title="source">Veter Dermatol.</span><span class="year" tagx="year" title="year">2020</span><span class="volume" tagx="volume" title="volume">31</span><span class="fpage" tagx="fpage" title="fpage">81</span><span class="pub-id"><a href="https://dx.doi.org/10.1111/vde.12807">10.1111/vde.12807</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/31729809">31729809</a></span></span></li> <li tag="ref"><a name="B51-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">51.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bensignor</span><span class="given-names" tagx="given-names" title="given-names">E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">FabriÃ¨s</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bailleux</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span></span><span class="mixed-article-title" title="mixed-article-title">A split-body, randomized, blinded study to evaluate the efficacy of a topical spray composed of essential oils and essential fatty acids from plant extracts with antimicrobial properties</span><span class="source" tagx="source" title="source">Veter Dermatol.</span><span class="year" tagx="year" title="year">2016</span><span class="volume" tagx="volume" title="volume">27</span><span class="fpage" tagx="fpage" title="fpage">464</span><span class="pub-id"><a href="https://dx.doi.org/10.1111/vde.12374">10.1111/vde.12374</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/27597636">27597636</a></span></span></li> <li tag="ref"><a name="B52-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">52.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Filoche</span><span class="given-names" tagx="given-names" title="given-names">S.K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Soma</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sissons</span><span class="given-names" tagx="given-names" title="given-names">C.H.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Antimicrobial effects of essential oils in combination with chlorhexidine digluconate</span><span class="source" tagx="source" title="source">Oral Microbiol. Immunol.</span><span class="year" tagx="year" title="year">2005</span><span class="volume" tagx="volume" title="volume">20</span><span class="fpage" tagx="fpage" title="fpage">221</span><span class="lpage" tagx="lpage" title="lpage">225</span><span class="pub-id"><a href="https://dx.doi.org/10.1111/j.1399-302X.2005.00216.x">10.1111/j.1399-302X.2005.00216.x</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/15943766">15943766</a></span></span></li> <li tag="ref"><a name="B53-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">53.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Schwiertz</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Duttke</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hild</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">MÃ¼ller</span><span class="given-names" tagx="given-names" title="given-names">H.J.</span></span></span><span class="mixed-article-title" title="mixed-article-title">In vitro activity of essential oils on microorganisms isolated from vaginal infections</span><span class="source" tagx="source" title="source">Int. J. Aromatherapy</span><span class="year" tagx="year" title="year">2006</span><span class="volume" tagx="volume" title="volume">16</span><span class="fpage" tagx="fpage" title="fpage">169</span><span class="lpage" tagx="lpage" title="lpage">174</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.ijat.2006.09.005">10.1016/j.ijat.2006.09.005</a></span></span></li> <li tag="ref"><a name="B54-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">54.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hammer</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Carson</span><span class="given-names" tagx="given-names" title="given-names">C.F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Riley</span><span class="given-names" tagx="given-names" title="given-names">T.V.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Antifungal effects of Melaleuca alternifolia (tea tree) oil and its components on Candida albicans, Candida glabrata and Saccharomyces cerevisiae</span><span class="source" tagx="source" title="source">J. Antimicrob. Chemother.</span><span class="year" tagx="year" title="year">2004</span><span class="volume" tagx="volume" title="volume">53</span><span class="fpage" tagx="fpage" title="fpage">1081</span><span class="lpage" tagx="lpage" title="lpage">1085</span><span class="pub-id"><a href="https://dx.doi.org/10.1093/jac/dkh243">10.1093/jac/dkh243</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/15140856">15140856</a></span></span></li> <li tag="ref"><a name="B55-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">55.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lee</span><span class="given-names" tagx="given-names" title="given-names">Y.S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kim</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lee</span><span class="given-names" tagx="given-names" title="given-names">S.G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Oh</span><span class="given-names" tagx="given-names" title="given-names">E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shin</span><span class="given-names" tagx="given-names" title="given-names">S.C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Park</span><span class="given-names" tagx="given-names" title="given-names">I.K.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Effects of plant essential oils and components from Oriental sweetgum (Liquidambar orientalis) on growth and morphogenesis of three phytopathogenic fungi</span><span class="source" tagx="source" title="source">Pestic. Biochem. Physiol.</span><span class="year" tagx="year" title="year">2009</span><span class="volume" tagx="volume" title="volume">93</span><span class="fpage" tagx="fpage" title="fpage">138</span><span class="lpage" tagx="lpage" title="lpage">143</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.pestbp.2009.02.002">10.1016/j.pestbp.2009.02.002</a></span></span></li> <li tag="ref"><a name="B56-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">56.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Elisa</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Aldo</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ludovica</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Viviana</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Debora</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Massa</span><span class="given-names" tagx="given-names" title="given-names">N.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Giorgia</span><span class="given-names" tagx="given-names" title="given-names">N.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Elisa</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Chemical composition and antimycotic activity of six essential oils (cumin, fennel, manuka, sweet orange, cedar and juniper) against different Candida spp.</span><span class="source" tagx="source" title="source">Nat. Prod. Res.</span><span class="year" tagx="year" title="year">2019</span><span class="volume" tagx="volume" title="volume">11</span><span class="fpage" tagx="fpage" title="fpage">6</span><span class="pub-id"><a href="https://dx.doi.org/10.1080/14786419.2019.1696327">10.1080/14786419.2019.1696327</a></span></span></li> <li tag="ref"><a name="B57-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">57.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gonzalez-Audino</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Picollo</span><span class="given-names" tagx="given-names" title="given-names">M.I.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gallardo</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Toloza</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Vassena</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cueto</span><span class="given-names" tagx="given-names" title="given-names">G.M.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Comparative toxicity of oxygenated monoterpenoids in experimental hydroalcoholic lotions to permethrin-resistant adult head lice</span><span class="source" tagx="source" title="source">Arch. Dermatol. Res.</span><span class="year" tagx="year" title="year">2010</span><span class="volume" tagx="volume" title="volume">303</span><span class="fpage" tagx="fpage" title="fpage">361</span><span class="lpage" tagx="lpage" title="lpage">366</span><span class="pub-id"><a href="https://dx.doi.org/10.1007/s00403-010-1110-z">10.1007/s00403-010-1110-z</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21174108">21174108</a></span></span></li> <li tag="ref"><a name="B58-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">58.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">George</span><span class="given-names" tagx="given-names" title="given-names">D.R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sparagano</span><span class="given-names" tagx="given-names" title="given-names">O.A.E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Port</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Okello</span><span class="given-names" tagx="given-names" title="given-names">E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shiel</span><span class="given-names" tagx="given-names" title="given-names">R.S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Guy</span><span class="given-names" tagx="given-names" title="given-names">J.H.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Environmental interactions with the toxicity of plant essential oils to the poultry red miteDermanyssus gallinae</span><span class="source" tagx="source" title="source">Med. Veter Entomol.</span><span class="year" tagx="year" title="year">2010</span><span class="volume" tagx="volume" title="volume">24</span><span class="fpage" tagx="fpage" title="fpage">1</span><span class="lpage" tagx="lpage" title="lpage">8</span><span class="pub-id"><a href="https://dx.doi.org/10.1111/j.1365-2915.2009.00855.x">10.1111/j.1365-2915.2009.00855.x</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20377725">20377725</a></span></span></li> <li tag="ref"><a name="B59-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">59.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">George</span><span class="given-names" tagx="given-names" title="given-names">D.R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sparagano</span><span class="given-names" tagx="given-names" title="given-names">O.A.E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Port</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Okello</span><span class="given-names" tagx="given-names" title="given-names">E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shiel</span><span class="given-names" tagx="given-names" title="given-names">R.S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Guy</span><span class="given-names" tagx="given-names" title="given-names">J.H.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Toxicity of plant essential oils to different life stages of the poultry red mite, Dermanyssus gallinae, and non-target invertebrates</span><span class="source" tagx="source" title="source">Med. Veter Entomol.</span><span class="year" tagx="year" title="year">2010</span><span class="volume" tagx="volume" title="volume">24</span><span class="fpage" tagx="fpage" title="fpage">9</span><span class="lpage" tagx="lpage" title="lpage">15</span><span class="pub-id"><a href="https://dx.doi.org/10.1111/j.1365-2915.2009.00856.x">10.1111/j.1365-2915.2009.00856.x</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20377726">20377726</a></span></span></li> <li tag="ref"><a name="B60-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">60.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Park</span><span class="given-names" tagx="given-names" title="given-names">C.G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jang</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shin</span><span class="given-names" tagx="given-names" title="given-names">E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kim</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Myrtaceae Plant Essential Oils and their Î²-Triketone Components as Insecticides against Drosophila suzukii</span><span class="source" tagx="source" title="source">Molecules</span><span class="year" tagx="year" title="year">2017</span><span class="volume" tagx="volume" title="volume">22</span><span class="elocation-id" tagx="elocation-id" title="elocation-id">1050</span><span class="pub-id"><a href="https://dx.doi.org/10.3390/molecules22071050">10.3390/molecules22071050</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/28672824">28672824</a></span></span></li> <li tag="ref"><a name="B61-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">61.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Muturi</span><span class="given-names" tagx="given-names" title="given-names">E.J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ramirez</span><span class="given-names" tagx="given-names" title="given-names">J.L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Doll</span><span class="given-names" tagx="given-names" title="given-names">K.M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bowman</span><span class="given-names" tagx="given-names" title="given-names">M.J.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Combined Toxicity of Three Essential Oils Against Aedes aegypti (Diptera: Culicidae) Larvae</span><span class="source" tagx="source" title="source">J. Med. Entomol.</span><span class="year" tagx="year" title="year">2017</span><span class="volume" tagx="volume" title="volume">54</span><span class="fpage" tagx="fpage" title="fpage">1684</span><span class="lpage" tagx="lpage" title="lpage">1691</span><span class="pub-id"><a href="https://dx.doi.org/10.1093/jme/tjx168">10.1093/jme/tjx168</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/29029151">29029151</a></span></span></li> <li tag="ref"><a name="B62-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">62.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">George</span><span class="given-names" tagx="given-names" title="given-names">D.R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sparagano</span><span class="given-names" tagx="given-names" title="given-names">O.A.E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Port</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Okello</span><span class="given-names" tagx="given-names" title="given-names">E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shiel</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Guy</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Repellence of plant essential oils to Dermanyssus gallinae and toxicity to the non-target invertebrate Tenebrio molitor</span><span class="source" tagx="source" title="source">Veter Parasitol.</span><span class="year" tagx="year" title="year">2009</span><span class="volume" tagx="volume" title="volume">162</span><span class="fpage" tagx="fpage" title="fpage">129</span><span class="lpage" tagx="lpage" title="lpage">134</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.vetpar.2009.02.009">10.1016/j.vetpar.2009.02.009</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19264408">19264408</a></span></span></li> <li tag="ref"><a name="B63-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">63.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kendra</span><span class="given-names" tagx="given-names" title="given-names">P.E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Montgomery</span><span class="given-names" tagx="given-names" title="given-names">W.S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Niogret</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Deyrup</span><span class="given-names" tagx="given-names" title="given-names">M.A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">GuillÃ©n</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Epsky</span><span class="given-names" tagx="given-names" title="given-names">N.D.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Xyleborus glabratus, X. affinis, and X. ferrugineus (Coleoptera: Curculionidae: Scolytinae): Electroantennogram Responses to Host-Based Attractants and Temporal Patterns in Host-Seeking Flight</span><span class="source" tagx="source" title="source">Environ. Entomol.</span><span class="year" tagx="year" title="year">2012</span><span class="volume" tagx="volume" title="volume">41</span><span class="fpage" tagx="fpage" title="fpage">1597</span><span class="lpage" tagx="lpage" title="lpage">1605</span><span class="pub-id"><a href="https://dx.doi.org/10.1603/EN12164">10.1603/EN12164</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23321108">23321108</a></span></span></li> <li tag="ref"><a name="B64-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">64.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hanula</span><span class="given-names" tagx="given-names" title="given-names">J.L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sullivan</span><span class="given-names" tagx="given-names" title="given-names">B.T.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wakarchuk</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Variation in Manuka Oil Lure Efficacy for CapturingXyleborus glabratus (Coleoptera: Curculionidae: Scolytinae), and Cubeb Oil as an Alternative Attractant</span><span class="source" tagx="source" title="source">Environ. Entomol.</span><span class="year" tagx="year" title="year">2013</span><span class="volume" tagx="volume" title="volume">42</span><span class="fpage" tagx="fpage" title="fpage">333</span><span class="lpage" tagx="lpage" title="lpage">340</span><span class="pub-id"><a href="https://dx.doi.org/10.1603/EN12337">10.1603/EN12337</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23575024">23575024</a></span></span></li> <li tag="ref"><a name="B65-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">65.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kwon</span><span class="given-names" tagx="given-names" title="given-names">O.S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jung</span><span class="given-names" tagx="given-names" title="given-names">S.H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yang</span><span class="given-names" tagx="given-names" title="given-names">B.S.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Topical Administration of Manuka Oil Prevents UV-B Irradiation-Induced Cutaneous Photoaging in Mice</span><span class="source" tagx="source" title="source">Evid. Based Complement. Altern. Med.</span><span class="year" tagx="year" title="year">2013</span><span class="volume" tagx="volume" title="volume">2013</span><span class="fpage" tagx="fpage" title="fpage">1</span><span class="lpage" tagx="lpage" title="lpage">10</span><span class="pub-id"><a href="https://dx.doi.org/10.1155/2013/930857">10.1155/2013/930857</a></span></span></li> <li tag="ref"><a name="B66-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">66.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Park</span><span class="given-names" tagx="given-names" title="given-names">M.-I.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lee</span><span class="given-names" tagx="given-names" title="given-names">B.-J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lee</span><span class="given-names" tagx="given-names" title="given-names">S.W.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tag</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Soonkyu</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Vitamin C Derivative and Manuka Oil Surface Treated Composite Powder for Skin-Whitening and Wrinkle-Care</span><span class="patent" tagx="patent" title="patent">Patent KR101639615B1</span><span class="day" tagx="day" title="day">15</span><span class="month" tagx="month" title="month">7</span><span class="year" tagx="year" title="year">2016</span></span></li> <li tag="ref"><a name="B67-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">67.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Looker</span><span class="given-names" tagx="given-names" title="given-names">K.J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Garnett</span><span class="given-names" tagx="given-names" title="given-names">G.P.</span></span></span><span class="mixed-article-title" title="mixed-article-title">A systematic review of the epidemiology and interaction of herpes simplex virus types 1 and 2</span><span class="source" tagx="source" title="source">Sex. Transm. Infect.</span><span class="year" tagx="year" title="year">2005</span><span class="volume" tagx="volume" title="volume">81</span><span class="fpage" tagx="fpage" title="fpage">103</span><span class="lpage" tagx="lpage" title="lpage">107</span><span class="pub-id"><a href="https://dx.doi.org/10.1136/sti.2004.012039">10.1136/sti.2004.012039</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/15800084">15800084</a></span></span></li> <li tag="ref"><a name="B68-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">68.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Astani</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Reichling</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Schnitzler</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Screening for Antiviral Activities of Isolated Compounds from Essential Oils</span><span class="source" tagx="source" title="source">Evid. Based Complement. Altern. Med.</span><span class="year" tagx="year" title="year">2011</span><span class="volume" tagx="volume" title="volume">2011</span><span class="fpage" tagx="fpage" title="fpage">1</span><span class="lpage" tagx="lpage" title="lpage">8</span><span class="pub-id"><a href="https://dx.doi.org/10.1093/ecam/nep187">10.1093/ecam/nep187</a></span></span></li> <li tag="ref"><a name="B69-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">69.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Schnitzler</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wiesenhofer</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Reichling</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Comparative study on the cytotoxicity of different Myrtaceae essential oils on cultured vero and RC-37 cells</span><span class="source" tagx="source" title="source">Die Pharm.</span><span class="year" tagx="year" title="year">2008</span><span class="volume" tagx="volume" title="volume">63</span><span class="fpage" tagx="fpage" title="fpage">830</span><span class="lpage" tagx="lpage" title="lpage">835</span></span></li> <li tag="ref"><a name="B70-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">70.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Schnitzler</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Essential Oils for the Treatment of Herpes Simplex Virus Infections</span><span class="source" tagx="source" title="source">Chemotherapy</span><span class="year" tagx="year" title="year">2019</span><span class="volume" tagx="volume" title="volume">64</span><span class="fpage" tagx="fpage" title="fpage">1</span><span class="lpage" tagx="lpage" title="lpage">7</span><span class="pub-id"><a href="https://dx.doi.org/10.1159/000501062">10.1159/000501062</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/31234166">31234166</a></span></span></li> <li tag="ref"><a name="B71-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">71.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lis-Balchin</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hart</span><span class="given-names" tagx="given-names" title="given-names">S.L.</span></span></span><span class="mixed-article-title" title="mixed-article-title">An Investigation of the Actions of the Essential oils of Manuka (Leptospermum scoparium) and Kanuka (Kunzea ericoides), Myrtaceae on Guinea-pig Smooth Muscle</span><span class="source" tagx="source" title="source">J. Pharm. Pharmacol.</span><span class="year" tagx="year" title="year">1998</span><span class="volume" tagx="volume" title="volume">50</span><span class="fpage" tagx="fpage" title="fpage">809</span><span class="lpage" tagx="lpage" title="lpage">811</span><span class="pub-id"><a href="https://dx.doi.org/10.1111/j.2042-7158.1998.tb07144.x">10.1111/j.2042-7158.1998.tb07144.x</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/9720632">9720632</a></span></span></li> <li tag="ref"><a name="B72-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">72.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lis-Balchin</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Essential oils and â€™aromatherapyâ€™: Their modern role in healing</span><span class="source" tagx="source" title="source">J. R. Soc. Health</span><span class="year" tagx="year" title="year">1997</span><span class="volume" tagx="volume" title="volume">117</span><span class="fpage" tagx="fpage" title="fpage">324</span><span class="lpage" tagx="lpage" title="lpage">329</span><span class="pub-id"><a href="https://dx.doi.org/10.1177/146642409711700511">10.1177/146642409711700511</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/9519666">9519666</a></span></span></li> <li tag="ref"><a name="B73-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">73.</span><span class="element-citation'"><span class="person-group'"><span class="collab'">collab: Campo Research PTE Ltd.</span></span><span class="source" tagx="source" title="source">Manuka Oil Extract Leptospermum Scoparium</span><span class="publisher-name" tagx="publisher-name" title="publisher-name">Campo Research PTE Ltd.</span><span class="publisher-loc" tagx="publisher-loc" title="publisher-loc">Singapore</span><span class="year" tagx="year" title="year">2015</span></span></li> <li tag="ref"><a name="B74-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">74.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yoo</span><span class="given-names" tagx="given-names" title="given-names">J.-G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Han</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hong</span><span class="given-names" tagx="given-names" title="given-names">N.</span></span></span><span class="mixed-article-title" title="mixed-article-title">External Preparation for Antibacterial, Anti-Inflammatory and Skin Protection Containing Manuka Oil as a Main Ingredient</span><span class="patent" tagx="patent" title="patent">Patent KR19990016741A</span><span class="day" tagx="day" title="day">12</span><span class="month" tagx="month" title="month">5</span><span class="year" tagx="year" title="year">2003</span></span></li> <li tag="ref"><a name="B75-pharmaceuticals-13-00343" /><span class="label" tagx="label" title="label">75.</span><span class="element-citation'"><span class="mixed-article-title" title="mixed-article-title">Searching the Australian Register of Therapeutic Goods (ARTG)</span><span class="comment">Available online: <a href="https://www.tga.gov.au/searching-australian-register-therapeutic-goods-artg">https://www.tga.gov.au/searching-australian-register-therapeutic-goods-artg</a></span><span class="date-in-citation" tagx="date-in-citation" title="date-in-citation">(accessed on 1 July 2020)</span></span></li> </ul> </div> </div> <div class="floats-group" title="floats-group"> <div class="table-wrap_UNKNOWN" id="pharmaceuticals-13-00343-t001" orientation="portrait" position="float">
pharmaceuticals-13-00343-t001_Table 1<span class="label" tagx="label" title="label">Table 1</span> <p>Chemical composition of MÄ�nuka oil and known properties of each component.</p>  <table frame="hsides" rules="groups"> <thead> <tr> <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Component</th> <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Percentage in Commercial Compositions</th> <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">IUPAC Name</th> <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Known Properties</th> <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Ref.</th> </tr> </thead> <tbody> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Î±-pinene</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Up to 21.5%</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><span class="inline-graphic" title="inline-graphic" /></td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reported to have antibiotic resistance modulation, anticoagulant, antitumor, antimicrobial, antimalarial, antioxidant, anti-inflammatory, anti-Leishmania, and analgesic effects in association with other essential oils.</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B16-pharmaceuticals-13-00343">16</a>,<a href="#B17-pharmaceuticals-13-00343">17</a>]</td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Leptospermone </td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.8â€"19.4%</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6-isovaleryl-2,2,4,4-tetramethyl-1,3,5-cyclohexanetrione<br /><br /><span class="inline-graphic" title="inline-graphic" /></td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Herbicidal; antibacterial: treatment with 5â€"20 mg/disc of concentrate was effective against foodborne bacteria: <i>Listeria monocytogenes, Staphylococcus aureus and Staphylococcus intermedius</i> and three Gram-negative bacteria: <i>Salmonella typhimurium, Shigella flexneri and Shigella sonnei</i></td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B18-pharmaceuticals-13-00343">18</a>,<a href="#B19-pharmaceuticals-13-00343">19</a>,<a href="#B20-pharmaceuticals-13-00343">20</a>]</td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Calamenene</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.5â€"18.5%</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1,6-Dimethyl-4-isopropyltetralin<br /><br /><span class="inline-graphic" title="inline-graphic" /></td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Major constituent of mÄ�nuka oil; contributes to insecticidal, antiseptic, bactericidal, analgesic and anti-inflammatory properties.<br /><br /> Antibacterial effect against <i>S. aureus</i> and MRSA was shown.</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B12-pharmaceuticals-13-00343">12</a>,<a href="#B21-pharmaceuticals-13-00343">21</a>]</td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Î´-cadinene</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.9â€"6.9%</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><span class="inline-graphic" title="inline-graphic" /></td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pesticidal effects against mosquito have been shown for constituents isolated from <i>Kadsura heteroclita</i> leaf oil.</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B22-pharmaceuticals-13-00343">22</a>] </td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cadina-1,4-diene </td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.1â€"5.9%</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><span class="inline-graphic" title="inline-graphic" /></td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Not reported </td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" /> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cadina-3,5-diene</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.0â€"10.0%</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><span class="inline-graphic" title="inline-graphic" /></td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Not reported</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" /> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Flavesone </td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.7â€"5.8%</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2,2,4,4-Tetramethyl-6-(3-methylbutanoyl)cyclohexane-1,3,5-trione<br /><br /><span class="inline-graphic" title="inline-graphic" /></td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antiviral properties.</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B23-pharmaceuticals-13-00343">23</a>]</td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Î±-copaene</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.3â€"6.5%</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(1R,2S,6S,7S,8S)-8-isopropyl-1,3-dimethyltricyclo[4.4.0.02,7]dec-3-ene<br /><br /><span class="inline-graphic" title="inline-graphic" /><br /><br /> C<sub>15</sub>H<sub>24</sub></td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Enhances mating in male Mediterranean fruit flies; Lures for trapping Redbay ambrosia beetle (<i>Xyleborus glabratus</i>).</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B24-pharmaceuticals-13-00343">24</a>,<a href="#B25-pharmaceuticals-13-00343">25</a>] </td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Î±-selinene</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.3â€"5.0%</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7-Epi-alpha-Selinene<br /><br /><span class="inline-graphic" title="inline-graphic" /><br /><br /> Î±-selinene<br /><br /> C<sub>15</sub>H<sub>24</sub></td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Insecticidal: retarding the growth of mosquito larvae. </td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B21-pharmaceuticals-13-00343">21</a>]</td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Î±-terpineol </td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1â€"2%</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2-(4-methylcyclohex-3-en-1-yl)propan-2-ol<br /><br /><span class="inline-graphic" title="inline-graphic" /><br /><br /> C<sub>10</sub>H<sub>18</sub>O</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antifungal effects; preservative for the postharvest storage of grapes and other fruits; has been shown to suppress the production of inflammatory mediators when sourced from Tea tree oil.</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B26-pharmaceuticals-13-00343">26</a>,<a href="#B27-pharmaceuticals-13-00343">27</a>]</td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">terpinene-4-ol</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.8â€"1.4%</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4-methyl-1-propan-2-ylcyclohex-3-en-1-ol<br /><br /><span class="inline-graphic" title="inline-graphic" /><br /><br /> C<sub>10</sub>H<sub>18</sub>O</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Spasmolytic activity; anti-inflammatory properties have been characterized in constituent isolated from <i>Melaleuca alternifolia</i>. </td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B28-pharmaceuticals-13-00343">28</a>]</td> </tr> </tbody> </table> <div class="table-wrap-foot_UNKNOWN"> <div class="fn-type-" title=""> <p>* IUPAC names were obtained from <span class="uri" title="uri"><a href="https://pubchem.ncbi.nlm.nih.gov/compound/">https://pubchem.ncbi.nlm.nih.gov/compound/</a></span>; Chemical structures were obtained from <span class="uri" title="uri"><a href="https://pubchem.ncbi.nlm.nih.gov/">https://pubchem.ncbi.nlm.nih.gov/</a></span>.</p> </div> </div> </div> <div class="table-wrap_UNKNOWN" id="pharmaceuticals-13-00343-t002" orientation="portrait" position="float">
pharmaceuticals-13-00343-t002_Table 2<span class="label" tagx="label" title="label">Table 2</span> <p>Antibacterial activity of MÄ�nuka oil.</p>  <table frame="hsides" rules="groups"> <thead> <tr> <th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Organism</th> <th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Method of Analysis</th> <th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">%(vol/vol) (Âµg/mL)</th> <th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Relevance</th> <th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Ref.</th> </tr> <tr> <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><sup>#</sup> MIC</th> <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">* MBC</th> </tr> </thead> <tbody> <tr> <td colspan="6" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><b><i>Gram positive bacteria</i></b></td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><i>Atopobium vaginae</i></td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Broth microdilution</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vaginal infections, pre-term birth and neonatal infections</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B53-pharmaceuticals-13-00343">53</a>]</td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><i>Bacillus subtilis</i></td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Broth microdilution</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.03</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.50</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Intestinal bacteria</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B35-pharmaceuticals-13-00343">35</a>]</td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><i>Bacteroides vulgatus</i></td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Broth microdilution</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vaginal infections, pre-term birth and neonatal infections</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B53-pharmaceuticals-13-00343">53</a>]</td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><i>Lactobacillus plantarum</i></td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Broth microdilution</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12.5</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Not reported</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oral probiotic</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B52-pharmaceuticals-13-00343">52</a>]</td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">H<sub>2</sub>O<sub>2</sub>-producing <i>lactobacilli and</i> non H<sub>2</sub>O<sub>2</sub>-producing <i>lactobacilli</i></td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Broth microdilution</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.075</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.075</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vaginal bacteria</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B53-pharmaceuticals-13-00343">53</a>]</td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><i>Listeria monocytogenes</i></td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Two-fold serial dilution </td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.414</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Not reported</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Foodborne pathogen</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B49-pharmaceuticals-13-00343">49</a>]</td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><i>Gardnerella vaginalis</i></td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Broth microdilution</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vaginal infections, pre-term birth and neonatal infections</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B53-pharmaceuticals-13-00343">53</a>]</td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><i>Propionibacterium acnes</i> ATCC 11827</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Broth microdilution</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.055</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Not reported</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Acne</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B41-pharmaceuticals-13-00343">41</a>]</td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><i>Propionibacterium acnes</i></td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Broth microdilution</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.211</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.25</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Acne</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B43-pharmaceuticals-13-00343">43</a>]</td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><i>Staphylococcus aureus</i></td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Twoâ€˜-fold serial dilution </td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.535</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Not reported</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Foodborne pathogen</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B49-pharmaceuticals-13-00343">49</a>]</td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><i>S. aureus</i> strains</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Two-fold serial dilution</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.513</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Not reported</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Multiple clinical manifestations in humans</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B36-pharmaceuticals-13-00343">36</a>]</td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Methicillin-resistant <i>S. aureus</i></td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Broth microdilution</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.03</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.0</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Skin infections, pneumonia, sepsis, surgical site infections</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B35-pharmaceuticals-13-00343">35</a>]</td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><i>Streptococcus agalactiae</i></td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Broth microdilution</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Meningitis; sepsis</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B53-pharmaceuticals-13-00343">53</a>]</td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><i>Staphylococcus epidermidis</i> ATCC 2223</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Broth microdilution</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.40</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Not reported</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Acne</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B41-pharmaceuticals-13-00343">41</a>]</td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><i>S. intermedius</i></td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Broth microdilution</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0581</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Not reported</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Foodborne pathogen</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B49-pharmaceuticals-13-00343">49</a>]</td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><i>S. sorbinus</i></td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Broth microdilution</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.048</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Not reported</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oral pathogen</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B36-pharmaceuticals-13-00343">36</a>]</td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><i>S. sorbinus</i> 6715</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">96-well liquid culture microdilution</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.13</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.25</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oral pathogen</td> <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<a href="#B38-pharmaceuticals-13-00343">38</a>]</td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><i>S. sorbinus</i> B13</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">96-well liquid culture microdilution</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.25</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.25</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oral pathogen</td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><i>S. mutans</i> JC2</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">96-well liquid culture microdilution</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.25</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.25</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oral pathogen</td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><i>S. mutans</i> ATCC 25175</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Two-fold microdilution</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.2</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Not reported</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oral pathogen; dental caries</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B52-pharmaceuticals-13-00343">52</a>]</td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vancomycin-resistant <i>Enterococcus faecalis</i> (VRE)</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Broth microdilution</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0064</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Not reported</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sepsis; infection of open wounds</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B45-pharmaceuticals-13-00343">45</a>]</td> </tr> <tr> <td colspan="6" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><b><i>Gram negative bacteria</i></b></td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><i>Actinobacillus actinomycetemcomitans (now known as Aggregatibacter actinomycetemcomitans) strains Y4, ATCC 29523, 29524, 33384</i></td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">96-well liquid culture microdilution</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.03</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.13</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oral pathogen</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B38-pharmaceuticals-13-00343">38</a>]</td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><i>Escherichia coli</i></td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Broth microdilution</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&amp;gt;4</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&amp;gt;4</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Intestinal bacteria; opportunistic pathogen</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B35-pharmaceuticals-13-00343">35</a>]</td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><i>E. coli</i> antibiotic and multidrug resistant strains</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Two-fold microdilution</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1â€"4</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2â€"4</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hospital-based infections</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B50-pharmaceuticals-13-00343">50</a>]</td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><i>Fusobacterium nucleatum</i> ATCC 25586 <i>strains</i></td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Broth microdilution</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.03</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.03</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Periodontal disease; dental caries</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B50-pharmaceuticals-13-00343">50</a>]</td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><i>H. pylori</i></td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Broth microdilution</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Not reported</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.4</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gastritis, gastric ulcers and gastric cancer</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B46-pharmaceuticals-13-00343">46</a>]</td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><i>Klebsiella pneumoniae spp.</i> antibiotics and multidrug resistant isolates</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Microdilution</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2â€"4</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2â€"8</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hospital-based infections; opportunistic pathogen</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B50-pharmaceuticals-13-00343">50</a>]</td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><i>Porphyromonas gingivalis</i> ATCC 33277, W50 and Su63</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">96-well liquid culture microdilution</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.03</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.06</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oral pathogen</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B38-pharmaceuticals-13-00343">38</a>]</td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><i>P. gingivalis</i> ATCC 53977</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">96-well liquid culture microdilution</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.03</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.03</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oral pathogen</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B38-pharmaceuticals-13-00343">38</a>]</td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><i>Pseudomonas aeruginosa</i> antibiotic and multidrug resistant isolates</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Two-fold microdilution</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">â‰¥8</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">â‰¥8</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Burn wound infections, sepsis</td> <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<a href="#B50-pharmaceuticals-13-00343">50</a>]</td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><i>Proteus mirabilis</i></td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Two-fold microdilution</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1â€"4</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2â€"8</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hospital based infections</td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><i>Salmonella typhimurium</i></td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Two-fold serial dilution</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.00236</td> <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Not reported </td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Foodborne bacteria</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B49-pharmaceuticals-13-00343">49</a>]</td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><i>S. flexneri</i></td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Two-fold serial dilution</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.00653</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Foodborne bacteria</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B49-pharmaceuticals-13-00343">49</a>]</td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><i>S. sonnei</i></td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Two-fold serial dilution</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.00697</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Foodborne bacteria</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B49-pharmaceuticals-13-00343">49</a>]</td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><i>Serratia marcescens</i></td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Broth microdilution</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">â‰¥4</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">â‰¥4</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Opportunistic pathogen</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B35-pharmaceuticals-13-00343">35</a>]</td> </tr> </tbody> </table> <div class="table-wrap-foot_UNKNOWN"> <div class="fn-type-" title=""> <p>* MIC: Minimum inhibitory concentration: minimum dose required to inhibit growth of bacteria; <sup>#</sup> MBC: Minimum bactericidal concentration: minimum dose required to kill bacteria.</p> </div> </div> </div> <div class="table-wrap_UNKNOWN" id="pharmaceuticals-13-00343-t003" orientation="portrait" position="float">
pharmaceuticals-13-00343-t003_Table 3<span class="label" tagx="label" title="label">Table 3</span> <p>Antifungal activity of MÄ�nuka oil.</p>  <table frame="hsides" rules="groups"> <thead> <tr> <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Organism</th> <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">* MIC (% <i>v</i>/<i>v</i>)</th> <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><sup>#</sup> MFC (% <i>v</i>/<i>v</i>)</th> <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Relevance</th> <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Ref.</th> </tr> </thead> <tbody> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><i>Malassezia furfur</i></td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.56</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Not reported</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pityriasis versicolor and Pityrosporum folliculitis</td> <td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<a href="#B37-pharmaceuticals-13-00343">37</a>]</td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><i>Trichosporon mucoides</i></td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.56</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Not reported</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Opportunistic pathogen</td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><i>Candida albicans</i></td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.13</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Not reported</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Opportunistic pathogen</td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><i>Candida tropicalis</i></td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.13</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Not reported</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Opportunistic pathogen</td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><i>Candida albicans</i></td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.015 </td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.015</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Candida vulvovaginitis infections</td> <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<a href="#B53-pharmaceuticals-13-00343">53</a>]</td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><i>Candida glabrata</i></td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.010</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.010</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vaginal candidiasis</td> </tr> </tbody> </table> <div class="table-wrap-foot_UNKNOWN"> <div class="fn-type-" title=""> <p>* MIC: Minimum inhibitory concentration; <sup>#</sup> MFC: Minimum Fungicidal concentration. Both values were determined using microdilution assays.</p> </div> </div> </div> <div class="table-wrap_UNKNOWN" id="pharmaceuticals-13-00343-t004" orientation="portrait" position="float">
pharmaceuticals-13-00343-t004_Table 4<span class="label" tagx="label" title="label">Table 4</span> <p>Antiparasitic or insecticidal effect of MÄ�nuka oil.</p>  <table frame="hsides" rules="groups"> <thead> <tr> <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Organism</th> <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Method</th> <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Lethal Effect</th> <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Clinical Significance</th> <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Ref.</th> </tr> </thead> <tbody> <tr> <td colspan="5" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><b>Acaricidal activity</b></td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><i>Dermanyssus gallinae</i></td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Contact assay</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LC<sub>50</sub>: 0.02 to 0.03, LC<sub>90</sub>:0.05 to 0.07<br /><br /> LD<sub>99</sub>: 0.10 mg/cm<sup>2</sup></td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Poultry red mite</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B58-pharmaceuticals-13-00343">58</a>,<a href="#B59-pharmaceuticals-13-00343">59</a>]</td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><i>D. farinae</i></td> <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Fabricated disc method</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LD<sub>50</sub>: 0.54 Î¼g/cm<sup>2</sup></td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">House dust mite</td> <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<a href="#B20-pharmaceuticals-13-00343">20</a>]</td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><i>D. pteronyssinus</i></td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LD<sub>50</sub>: 0.67 Î¼g/cm<sup>2</sup></td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">House dust mite</td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><i>Tyrophagus putrescentiae</i></td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LD<sub>50</sub>: 1.21 Î¼g/cm<sup>2</sup></td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Stored product mite</td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><i>Sarcoptes scabei</i></td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Contact assay</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LT<sub>50</sub>: 60 min for 5% solution<br /><br /> LT<sub>50</sub>: 30 min for 10% solution</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Human scabies mites</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B14-pharmaceuticals-13-00343">14</a>]</td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><i>Drosophila suzukii</i></td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Contact assay</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.60 Î¼g/mL for males and 1.10 for females</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fruit fly pest</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B60-pharmaceuticals-13-00343">60</a>]</td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><i>Aedes aegypti</i> (Linnaeus) larvae</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Larvicidal bioassay</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LC<sub>90</sub>: 66.62</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Malaria</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B21-pharmaceuticals-13-00343">21</a>,<a href="#B61-pharmaceuticals-13-00343">61</a>]</td> </tr> <tr> <td colspan="5" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><b>Repellent effects</b></td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><i>Dermanyssus gallinae (De Geer)</i></td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fumigant assay</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">80â€"84%</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Poultry red mite</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B62-pharmaceuticals-13-00343">62</a>]</td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><i>Dermanyssus gallinae</i></td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fumigant assay</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">80%</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Poultry red mite</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B8-pharmaceuticals-13-00343">8</a>,<a href="#B59-pharmaceuticals-13-00343">59</a>]</td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><i>Sarcoptes scabei</i></td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fumigant assay</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">80%</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Human scabies mites</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B14-pharmaceuticals-13-00343">14</a>]</td> </tr> </tbody> </table> </div> <div class="table-wrap_UNKNOWN" id="pharmaceuticals-13-00343-t005" orientation="portrait" position="float">
pharmaceuticals-13-00343-t005_Table 5<span class="label" tagx="label" title="label">Table 5</span> <p>Cytotoxicity of MÄ�nuka oil in vitro.</p>  <table frame="hsides" rules="groups"> <thead> <tr> <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Cell Line</th> <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Assay</th> <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Test</th> <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">* TC<sub>50</sub></th> <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Control</th> <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Ref.</th> </tr> </thead> <tbody> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RC-37 cells (African green monkey kidney cells)</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Neutral red assay after treatment for 72 h</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Î²-pinene</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.006%</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1% ethanol</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B68-pharmaceuticals-13-00343">68</a>]</td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RC-37 cells (African green monkey kidney cells)</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Neutral red assay after treatment for 96 h</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MÄ�nuka oil<br /><br /> Leptospermone</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0042%<br /><br /> 0.04%</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.6% ethanol</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B68-pharmaceuticals-13-00343">68</a>]</td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">THP-1 (monocyte/macrophage cell line)</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">XTT cell viability assay after 48 h of treatment</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.1â€"10% dissolved in DMSO</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No toxicity</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DMSO</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B37-pharmaceuticals-13-00343">37</a>]</td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vero (African green monkey kidney cells)</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Neutral red assay 96 h after treatment</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MÄ�nuka oil (0.001% to 1%)<br /><br /> Leptospermone</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0042%<br /><br /> 0.04%</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1% ethanol</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B69-pharmaceuticals-13-00343">69</a>]</td> </tr> <tr> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HUVEC (Human umbilical vein endothelial cells)</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cell Titre Assay</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MÄ�nuka oil</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">~0.4%</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No treatment</td> <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B38-pharmaceuticals-13-00343">38</a>]</td> </tr> </tbody> </table> <div class="table-wrap-foot_UNKNOWN"> <div class="fn-type-" title=""> <p>* TC<sub>50</sub>; the concentration of drug that reduces the number of viable cells by 50%.</p> </div> </div> </div> </div>  </body></html>